U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Nikolich K, Hyman SE, editors. Translational Neuroscience: Toward New Therapies [Internet]. Cambridge (MA): MIT Press; 2015.

Cover of Translational Neuroscience

Translational Neuroscience: Toward New Therapies [Internet].

Show details

Bibliography

    Note: Numbers in square brackets denote the chapter in which an entry is cited.

  • Adler, L., E. Pachtman, R. Franks, et al. 1982. Neurophysiological Evidence for a Defect in Neuronal Mechanisms Involved in Sensory Gating in Schizophrenia. Biol. Psychiatry 17:639–654. [10] [PubMed: 7104417]
  • Albin, R. L., A. B. Young, and J. B. Penney. 1989. The Functional Anatomy of Basal Ganglia Disorders. Trends Neurosci. 12:366–375. [9] [PubMed: 2479133]
  • Alvarez, V. A., D. A. Ridenour, and B. L. Sabatini. 2006. Retraction of Synapses and Dendritic Spines Induced by Off-Target Effects of RNA Interference. J. Neurosci. 26:7820–7825. [10] [PMC free article: PMC6674211] [PubMed: 16870727]
  • Amat, J., M. V. Baratta, E. Paul, et al. 2005. Medial Prefrontal Cortex Determines How Stressor Controllability Affects Behavior and Dorsal Raphé Nucleus. Nature Neurosci. 8(3):365–371. [12] [PubMed: 15696163]
  • Amir, R. E., I. B. Van den Veyver, M. Wan, et al. 1999. Rett Syndrome Is Caused by Mutations in X-Linked MECP2, Encoding Methyl-CpG-Binding Protein 2. Nat. Genet. 23(2):185–188. [2] [PubMed: 10508514]
  • Amminger, G. P., M. R. Schafer, K. Papageorgiou, et al. 2010. Long-Chain Omega-3 Fatty Acids for Indicated Prevention of Psychotic Disorders: A Randomized, Placebo-Controlled Trial. Arch. Gen. Psychiatry 67(2):146–154. [4] [PubMed: 20124114]
  • Amoroso, M. W., G. F. Croft, D. J. Williams, et al. 2013. Accelerated High-Yield Generation of Limb-Innervating Motor Neurons from Human Stem Cells. J. Neurosci. 33:574–586. [11] [PMC free article: PMC3711539] [PubMed: 23303937]
  • Anderson, M. H. C., M. R. Munafo, and E. S. J. Robinson. 2013. Investigating the Psychopharmacology of Cognitive Affective Bias in Rats Using an Affective Tone Discrimination Task. Psychopharmacology 226:601–613. [12] [PubMed: 23239131]
  • Anderson, S., and P. Vanderhaeghen. 2014. Cortical Neurogenesis from Pluripotent Stem Cells: Complexity Emerging from Simplicity. Curr. Opin. Neurobiol. 27C:151–157. [10] [PMC free article: PMC4386058] [PubMed: 24747604]
  • Andreasen, N. C. 1989. The American Concept of Schizophrenia. Schizophr. Bull. 15(4):519–531. [4] [PubMed: 2696083]
  • Andreasen, N. C. 2007. DSM and the Death of Phenomenology in America: An Example of Unintended Consequences. Schizophr. Bull. 33(1):108–112. [4] [PMC free article: PMC2632284] [PubMed: 17158191]
  • Anney, R., L. Klei, D. Pinto, et al. 2012. Individual Common Variants Exert Weak Effects on the Risk for Autism Spectrum Disorders. Hum. Mol. Genet. 21(21):4781–4492. [2] [PMC free article: PMC3471395] [PubMed: 22843504]
  • Antal, A., L. Chaieb, V. Moliadze, et al. 2010. Brain-Derived Neurotrophic Factor (BDNF) Gene Polymorphisms Shape Cortical Plasticity in Humans. Brain Stimul. 3:230–237. [10] [PubMed: 20965453]
  • Araki, T., Y. Sasaki, and J. Milbrandt. 2004. Increased Nuclear NAD Biosynthesis and SIRT1 Activation Prevent Axonal Degeneration. Science 305(5686):1010–1013. [7] [PubMed: 15310905]
  • Arguello, P. A., and J. Gogos. 2006. Modeling Madness in Mice: One Piece at a Time. Neuron 52:179–196. [12] [PubMed: 17015235]
  • Arrowsmith, J. 2011. Trial Watch: Phase III and Submission Failures: 2007–2010. Nat. Rev. Drug Discov. 10(2):87. [13] [PubMed: 21283095]
  • Asanuma, K., C. Tang, Y. Ma, et al. 2006. Network Modulation in the Treatment of Parkinson’s Disease. Brain 12:2667–2678. [9] [PMC free article: PMC4459513] [PubMed: 16844713]
  • Asrican, B., G. J. Augustine, K. Berglund, et al. 2013. Next-Generation Transgenic Mice for Optogenetic Analysis of Neural Circuits. Front. Neural Circuits 7:160. [14] [PMC free article: PMC3840435] [PubMed: 24324405]
  • Atasoy, D., J. N. Betley, H. H. Su, and S. M. Sternson. 2012. Deconstruction of a Neural Circuit for Hunger. Nature 488:172–177. [10] [PMC free article: PMC3416931] [PubMed: 22801496]
  • Atwal, J. K., Y. Chen, C. Chiu, et al. 2011. A Therapeutic Antibody Targeting BACE1 Inhibits Amyloid-Beta Production in Vivo. Sci. Transl. Med. 3(84):84ra43. [7] [PubMed: 21613622]
  • Autism Genome Project Consortium, P. Szatmari, A. D. Paterson, et al. 2007. Mapping Autism Risk Loci Using Genetic Linkage and Chromosomal Rearrangements. Nat. Genet. 39(3):319–328. [4] [PMC free article: PMC4867008] [PubMed: 17322880]
  • Ayutyanont, N., J. B. Langbaum, S. B. Hendrix, et al. 2014. The Alzheimer’s Prevention Initiative Composite Cognitive Test Score: Sample Size Estimates for the Evaluation of Preclinical Alzheimer’s Disease Treatments in Presenilin 1 E280a Mutation Carriers. J. Clin. Psychiatry 75(6):652–660. [7] [PMC free article: PMC4331113] [PubMed: 24816373]
  • Ba, W., J. van der Raadt, and N. Nadif Kasri. 2013. Rho GTPase Signaling at the Synapse: Implications for Intellectual Disability. Exp. Cell Res. 319(15):2368–2374. [2] [PubMed: 23769912]
  • Baddeley, A. 1986. Working Memory. Oxford: Clarendon Press. [12]
  • Balleine, B. W., and J. P. O’Doherty. 2010. Human and Rodent Homologies in Action Control: Corticostriatal Determinants of Goal-Directed and Habitual Action. Neuropharmacology 35:48–69. [12] [PMC free article: PMC3055420] [PubMed: 19776734]
  • Barch, D. M., J. Bustillo, W. Gaebel, et al. 2013. Logic and Justification for Dimensional Assessment of Symptoms and Related Clinical Phenomena in Psychosis: Relevance to DSM-5. Schizophr. Res. 150(1):15–20. [4] [PubMed: 23706415]
  • Bari, A., D. M. Eagle, A. C. Mar, E. S. J. Robinson, and T.W. Robbins. 2009. Dissociable Effects of Noradrenaline, Dopamine, and Serotonin Uptake Blockade on Stop Task Performance in Rats. Psychopharmacology 205:273–283. [12] [PMC free article: PMC2705723] [PubMed: 19404616]
  • Bari, A., D. E. Theobald, D. Caprioli, et al. 2010. Serotonin Modulates Sensitivity to Reward and Negative Feedback in a Probabilistic Reversal Learning Task in Rats. Neuropsychopharmacology 35(6):1290–1301. [12] [PMC free article: PMC3055347] [PubMed: 20107431]
  • Barrett, C. E., A. C. Keebaugh, T. H. Ahern, et al. 2013. Variation in Vasopressin Receptor (Avpr1a) Expression Creates Diversity in Behaviors Related to Monogamy in Prairie Voles. Horm. Behav. 63:518–526. [10] [PMC free article: PMC3602142] [PubMed: 23370363]
  • Bartus, R. T., M. S. Weinberg, and R. J. Samulski. 2014. Parkinson’s Disease Gene Therapy: Success by Design Meets Failure by Efficacy. Mol. Ther. 22(3):487–497. [7] [PMC free article: PMC3944322] [PubMed: 24356252]
  • Bateman, R. J., C. Xiong, T. L. Benzinger, et al. 2012. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer’s Disease. N. Engl. J. Med. 367(9):795–804. [6, 7, 9] [PMC free article: PMC3474597] [PubMed: 22784036]
  • Baudouin, S. J., J. Gaudias, S. Gerharz, et al. 2012. Shared Synaptic Pathophysiology in Syndromic and Nonsyndromic Rodent Models of Autism. Science 338(6103):128–132. [2] [PubMed: 22983708]
  • Bear, M. F., G. Dölen, E. Osterweil, and N. Nagarajan. 2008. Fragile X: Translation in Action. Neuropsychopharmacology 33:84–87. [10, 13] [PMC free article: PMC4327813] [PubMed: 17940551]
  • Bear, M. F., K. M. Huber, and S. T. Warren. 2004. The mGluR Theory of Fragile X Mental Retardation. Trends Neurosci. 27(7):370–377. [13] [PubMed: 15219735]
  • Beck, H., I. V. Goussakov, A. Lie, C. Helmstaedter, and C. E. Elger. 2000. Synaptic Plasticity in the Human Dentate Gyrus. J. Neurosci. 20:7080–7086. [10] [PMC free article: PMC6772802] [PubMed: 10995855]
  • Belin, D., A. C. Mar, J. W. J.W. Dalley, T. W. Robbins, and B. J. Everitt. 2008. High Impulsivity Predicts the Switch to Compulsive Cocaine-Taking. Science 320:1352–1355. [12] [PMC free article: PMC2478705] [PubMed: 18535246]
  • Benabid, A. L., S. Chabardes, J. Mitrofanis, and P. Pollak. 2009. Deep Brain Stimulation of the Subthalamic Nucleus for the Treatment of Parkinson’s Disease. Lancet Neurol. 8(1):67–81. [14] [PubMed: 19081516]
  • Benilova, I., E. Karran, and B. De Strooper. 2012. The Toxic Abeta Oligomer and Alzheimer’s Disease: An Emperor in Need of Clothes. Nat. Neurosci. 15(3):349–357. [7] [PubMed: 22286176]
  • Benzinger, T. L., T. Blazey, C. R. Jack, Jr., et al. 2013. Regional Variability of Imaging Biomarkers in Autosomal Dominant Alzheimer’s Disease. PNAS 110:E4502–E4509. [9] [PMC free article: PMC3839740] [PubMed: 24194552]
  • Bergman, H., T. Wichmann, B. Karmon, and M. R. DeLong. 1994. The Primate Subthalamic Nucleus. II. Neuronal Activity in the MPTP Model of Parkinsonism. J. Neurophysiol. 72:507–521. [9] [PubMed: 7983515]
  • Bergmann, C., K. Zerres, J. Senderek, et al. 2003. Oligophrenin 1 (OPHN1) Gene Mutation Causes Syndromic X-Linked Mental Retardation with Epilepsy, Rostral Ventricular Enlargement and Cerebellar Hypoplasia. Brain 126(Pt 7):1537–1544. [2] [PubMed: 12805098]
  • Berk, J. L., O. B. Suhr, L. Obici, et al. 2013. Repurposing Diflunisal for Familial Amyloid Polyneuropathy: A Randomized Clinical Trial. JAMA 310(24):2658–2667. [7] [PMC free article: PMC4139164] [PubMed: 24368466]
  • Berkel, S., C. R. Marshall, B. Weiss, et al. 2010. Mutations in the SHANK2 Synaptic Scaffolding Gene in Autism Spectrum Disorder and Mental Retardation. Nat. Genet. 42(6):489–491. [4] [PubMed: 20473310]
  • Berndt, A., S. Y. Lee, C. Ramakrishnan, and K. Deisseroth. 2014. Structure-Guided Transformation of Channelrhodopsin into a Light-Activated Chloride Channel. Science 344(6182):420–424. [8] [PMC free article: PMC4096039] [PubMed: 24763591]
  • Bero, A. W., A. Q. Bauer, F. R. Stewart, et al. 2012. Bidirectional Relationship between Functional Connectivity and Amyloid-Beta Deposition in Mouse Brain. J. Neurosci. 32:4334–4340. [9] [PMC free article: PMC3326343] [PubMed: 22457485]
  • Bero, A. W., P. Yan, J. H. Roh, et al. 2011. Neuronal Activity Regulates the Regional Vulnerability to Amyloid-Beta Deposition. Nat. Neurosci. 14:750–756. [9] [PMC free article: PMC3102784] [PubMed: 21532579]
  • Berry-Kravis, E., D. Hessl, L. Abbeduto, et al. 2013. Outcome Measures for Clinical Trials in Fragile X Syndrome. J. Dev. Behav. Pediatr. 34:508–522. [10] [PMC free article: PMC3784007] [PubMed: 24042082]
  • Bersani, F. S., A. Minichino, P. G. Enticott, et al. 2013. Deep Transcranial Magnetic Stimulation as a Treatment for Psychiatric Disorders: A Comprehensive Review. Eur. J. Psychiatry 28:30–39. [10] [PubMed: 22559998]
  • Bertram, L., C. Lange, K. Mullin, et al. 2008. Genome-Wide Association Analysis Reveals Putative Alzheimer’s Disease Susceptibility Loci in Addition to APOE. Am. J. Hum. Genet. 83(5):623–632. [7] [PMC free article: PMC2668052] [PubMed: 18976728]
  • Betancur, C., and J. D. Buxbaum. 2013. SHANK3 Haploinsufficiency: A “Common” but Underdiagnosed Highly Penetrant Monogenic Cause of Autism Spectrum Disorders. Mol. Autism 4(1):17. [4] [PMC free article: PMC3695795] [PubMed: 23758743]
  • Bezard, E., and S. Przedborski. 2011. A Tale on Animal Models of Parkinson’s Disease. Mov. Disord. 26(6):993–1002. [13] [PubMed: 21626544]
  • Bezzina, G., S. Body, T. H. Cheung, et al. 2008. Effect of Disconnecting the Orbital Prefrontal Cortex from the Nucleus Accumbens Core on Inter-Temporal Choice Behavior: A Quantitative Analysis. Behav. Brain Res. 191:272–279. [12] [PMC free article: PMC2424131] [PubMed: 18472170]
  • Bien-Ly, N., A. K. Gillespie, D. Walker, S. Y. Yoon, and Y. Huang. 2012. Reducing Human Apolipoprotein E Levels Attenuates Age-Dependent Abeta Accumulation in Mutant Human Amyloid Precursor Protein Transgenic Mice. J. Neurosci. 32(14):4803–4811. [7] [PMC free article: PMC3433173] [PubMed: 22492035]
  • Biglan, K. M., Y. Zhang, J. D. Long, et al. 2013. Refining the Diagnosis of Huntington Disease: The PREDICT-HD Study. Front. Aging Neurosci. 5:12. [7] [PMC free article: PMC3613616] [PubMed: 23565093]
  • Bilican, B., A. Serio, S. J. Barmada, et al. 2012. Mutant Induced Pluripotent Stem Cell Lines Recapitulate Aspects of TDP-43 Proteinopathies and Reveal Cell-Specific Vulnerability. PNAS 198(15):5803–5808. [5] [PMC free article: PMC3326463] [PubMed: 22451909]
  • Bilican, B., A. Serio, S. J. Barmada, et al. 2013. Comment on “Drug Screening for ALS Using Patient-Specific Induced Pluripotent Stem Cells.” Sci. Transl. Med. 5(188):188le182. [5] [PMC free article: PMC3936961] [PubMed: 23740897]
  • Birks, J. 2006. Cholinesterase Inhibitors for Alzheimer’s Disease. Cochrane Database Syst. Rev.(1):CD005593. [7] [PMC free article: PMC9006343] [PubMed: 16437532]
  • Birman, S. 2008. Neurodegeneration: RNA Turns Number One Suspect in Polyglutamine Diseases. Curr. Biol. 18(15):R659–R661. [5] [PubMed: 18682207]
  • Birrell, J. M., and V. J. Brown. 2000. Medial Frontal Cortex Mediates Perceptual Attentional Set-Shifting in the Rat. J. Neurosci. 20:4320–4324. [12] [PMC free article: PMC6772641] [PubMed: 10818167]
  • Bishop, D. V. 2010. Which Neurodevelopmental Disorders Get Researched and Why? PLoS One 5(11):e15112. [2] [PMC free article: PMC2994844] [PubMed: 21152085]
  • Blennow, K., H. Zetterberg, and A. M. Fagan. 2012. Fluid Biomarkers in Alzheimer Disease. Cold Spring Harb. Perspect. Med. 2(9):a006221. [13] [PMC free article: PMC3426814] [PubMed: 22951438]
  • Blennow, K., H. Zetterberg, C. Haass, and T. Finucane. 2013. Semagacestat’s Fall: Where Next for AD Therapies? Nat. Med. 19(10):1214–1215. [6] [PubMed: 24100981]
  • Bliss, T. V. P., and S. F. Cooke. 2011. Long-Term Potentiation and Long-Term Depression: A Clinical Perspective. Clinics (Sao Paulo) 66(Suppl. 1):3–17. [10] [PMC free article: PMC3118435] [PubMed: 21779718]
  • Bloom, D. E., E. T. Cafiero, E. Jané-Llopis, S. Abrahams-Gessel, and L. R. e. a. Bloom. 2011. The Global Economic Burden of Noncommunicable Diseases. Geneva: World Economic Forum. [1]
  • Blumensath, T., S. Jbabdi, M. F. Glasser, et al. 2013. Spatially Constrained Hierarchical Parcellation of the Brain with Resting-State fMRI. Neuroimage 76:313–324. [9] [PMC free article: PMC3758955] [PubMed: 23523803]
  • Boch, J., H. Scholze, S. Schornack, et al. 2009. Breaking the Code of DNA Binding Specificity of TAL-Type III Effectors. Science 326:1509–1512. [8] [PubMed: 19933107]
  • Boissart, C., A. Poulet, P. Georges, et al. 2013. Differentiation from Human Pluripotent Stem Cells of Cortical Neurons of the Superficial Layers Amenable to Psychiatric Disease Modeling and High-Throughput Drug Screening. Transl. Psychiatry 3:e294. [2, 4] [PMC free article: PMC3756296] [PubMed: 23962924]
  • Bonaglia, M. C., R. Giorda, S. Beri, et al. 2011. Molecular Mechanisms Generating and Stabilizing Terminal 22q13 Deletions in 44 Subjects with Phelan/Mcdermid Syndrome. PLoS Genet. 7(7):e1002173. [4] [PMC free article: PMC3136441] [PubMed: 21779178]
  • Bourgeron, T. 2009. A Synaptic Trek to Autism. Curr. Opin. Neurobiol. 19(2):231–234. [2] [PubMed: 19545994]
  • Boutajangout, A., J. Ingadottir, P. Davies, and E. M. Sigurdsson. 2011. Passive Immunization Targeting Pathological Phospho-Tau Protein in a Mouse Model Reduces Functional Decline and Clears Tau Aggregates from the Brain. J. Neurochem. 118(4):658–667. [7] [PMC free article: PMC3366469] [PubMed: 21644996]
  • Boutros, N., G. Zouridakis, and J. Overall. 1991. Replication and Extension of P50 Findings in Schizophrenia. Clin. Electroencephalogr. 22:40–45. [10] [PubMed: 1991411]
  • Boyden, E. S., F. Zhang, E. Bamberg, G. Nagel, and K. Deisseroth. 2005. Millisecond-Timescale, Genetically Targeted Optical Control of Neural Activity. Nat. Neurosci. 8(9):1263–1268. [8, 10, 14] [PubMed: 16116447]
  • Bozdagi, O., T. Sakurai, D. Papapetrou, et al. 2010. Haploinsufficiency of the Autism-Associated Shank3 Gene Leads to Deficits in Synaptic Function, Social Interaction, and Social Communication. Mol. Autism 1(1):15. [2] [PMC free article: PMC3019144] [PubMed: 21167025]
  • Brecht, M., R. Naumann, F. Anjum, et al. 2011. The Neurobiology of Etruscan Shrew Active Touch. Philos. Trans. R. Soc. Lond. B 366:3026–3036. [10] [PMC free article: PMC3172601] [PubMed: 21969684]
  • Brennand, K. J., A. Simone, J. Jou, et al. 2011. Modelling Schizophrenia Using Human Induced Pluripotent Stem Cells. Nature 473:221–225. [11] [PMC free article: PMC3392969] [PubMed: 21490598]
  • Brier, M. R., J. B. Thomas, A. Z. Snyder, et al. 2012. Loss of Intranetwork and Internetwork Resting State Functional Connections with Alzheimer’s Disease Progression. J. Neurosci. 32:8890–8899. [9] [PMC free article: PMC3458508] [PubMed: 22745490]
  • Briggman, K. L., M. Helmstaedter, and W. Denk. 2011. Wiring Specificity in the Direction-Selectivity Circuit of the Retina. Nature 471(7337):183–188. [8] [PubMed: 21390125]
  • Brockhaus-Dumke, A., R. Mueller, U. Faigle, and J. Klosterkoetter. 2008. Sensory Gating Revisited: Relation between Brain Oscillations and Auditory Evoked Potentials in Schizophrenia. Schizophr. Res. 99:238–249. [10] [PubMed: 18160261]
  • Brown, C. A., M. C. Campbell, M. Karimi, et al. 2012. Dopamine Pathway Loss in Nucleus Accumbens and Ventral Tegmental Area Predicts Apathetic Behavior in MPTP-Lesioned Monkeys. Exp. Neurol. 236:190–197. [9] [PMC free article: PMC3367030] [PubMed: 22579525]
  • Brown, C. A., M. K. Karimi, L. Tian, et al. 2013. Validation of Midbrain Positron Emission Tomography Measures for Nigrostriatal Neurons in Macaques. Ann. Neurol. 74:602–610. [9, 10] [PMC free article: PMC3800272] [PubMed: 23686841]
  • Burchell, V. S., D. E. Nelson, A. Sanchez-Martinez, et al. 2013. The Parkinson’s Disease-Linked Proteins Fbxo7 and Parkin Interact to Mediate Mitophagy. Nat. Neurosci. 16(9):1257–1265. [5] [PMC free article: PMC3827746] [PubMed: 23933751]
  • Bussey, T. J., A. Holmes, L. Lyon, et al. 2012. New Translational Assays for Preclinical Modeling of Cognition in Schizophrenia; the Touch-Screen Testing Method for Mice and Rats. Neuropharmacology 62:1191–1203. [12] [PMC free article: PMC3168710] [PubMed: 21530550]
  • Bussey, T. J., J. L. Muir, and T. W. Robbins. 1994. A Novel Automated Touchscreen Procedure for Assessing Learning in the Rat Using Computer Graphic Stimuli. Neurosci. Res. Comm. 15:103–110. [12]
  • Bütefisch, C. M., V. Khurana, L. Kopylev, and L. G. Cohen. 2004. Enhancing Encoding of a Motor Memory in the Primary Motor Cortex by Cortical Stimulation. J. Neurophysiol. 91:2110–2116. [10] [PubMed: 14711974]
  • Button, K. S., J. P. Ioannidis, C. Mokrysz, et al. 2013. Power Failure: Why Small Sample Size Undermines the Reliability of Neuroscience. Nat. Rev. Neurosci. 14(5):365–376. [3] [PubMed: 23571845]
  • Cahan, P., and G. Q. Daley. 2013. Origins and Implications of Pluripotent Stem Cell Variability and Heterogeneity. Nat. Rev. Mol. Cell. Biol. 14:357–368. [11] [PMC free article: PMC3980962] [PubMed: 23673969]
  • Callaway, E. M. 2008. Transneuronal Circuit Tracing with Neurotropic Viruses. Curr. Opin. Neurobiol. 18:617–623. [10] [PMC free article: PMC2698966] [PubMed: 19349161]
  • Campbell, C. D., and E. E. Eichler. 2013. Properties and Rates of Germline Mutations in Humans. Trends Genet. 29(10):575–584. [2] [PMC free article: PMC3785239] [PubMed: 23684843]
  • Campbell, M. C., J. Markham, H. Flores, et al. 2013. Principal Component Analysis of PiB Distribution in Parkinson and Alzheimer Diseases. Neurology 81:520–527. [10] [PMC free article: PMC3775684] [PubMed: 23825179]
  • Cannon, T. D. 2014. Neurocognitive Growth Charts and Psychosis: Is the Relationship Predictive? JAMA Psychiatry 71(4):361–362. [4] [PubMed: 24499862]
  • Cannon, T. D., K. Cadenhead, B. Cornblatt, et al. 2008. Prediction of Psychosis in Youth at High Clinical Risk: A Multisite Longitudinal Study in North America. Arch. Gen. Psychiatry 65(1):28–37. [4] [PMC free article: PMC3065347] [PubMed: 18180426]
  • Cao, G., J. Platisa, V. A. Pieribone, et al. 2013. Genetically Targeted Optical Electrophysiology in Intact Neural Circuits. Cell 154:904–913. [10] [PMC free article: PMC3874294] [PubMed: 23932121]
  • Capitanio, J. P., and M. E. Emborg. 2008. Contributions of Non-Human Primates to Neuroscience Research. Lancet 371(9618):1126–1135. [13] [PubMed: 18374844]
  • Cardinal, R. N., D. R. Pennicott, C. L. Sugathapala, T. W. Robbins, and B. J. Everitt. 2001. Impulsive Choice Induced in Rats by Lesions of the Nucleus Accumbens Core. Science 292:2499–2501. [12] [PubMed: 11375482]
  • Cardno, A. G., E. J. Marshall, B. Coid, et al. 1999. Heritability Estimates for Psychotic Disorders: The Maudsley Twin Psychosis Series. Arch. Gen. Psychiatry 56:162–168. [8] [PubMed: 10025441]
  • Cardno, A. G., and M. J. Owen. 2014. Genetic Relationships between Schizophrenia, Bipolar Disorder and Schizoaffective Disorder. Schizophr. Bull. 40(3):504–515. [3] [PMC free article: PMC3984527] [PubMed: 24567502]
  • Carey, J. R., F. Fregni, and A. Pascual-Leone. 2006. rTMS Combined with Motor Learning Training in Healthy Subjects. Restor. Neurol. Neurosci. 24:191–199. [10] [PubMed: 16873974]
  • Carli, M., J. L. Evenden, and T. W. Robbins. 1985. Depletion of Unilateral Striatal Dopamine Impairs Initiation of Contralateral Actions and Not Sensory Attention. Nature 313:679–682. [12] [PubMed: 3974701]
  • Carlsson, A. 2002. Treatment of Parkinson’s with L-DOPA. The Early Discovery Phase, and a Comment on Current Problems. J. Neural Transm. 109(5–6):777–787. [13] [PubMed: 12111467]
  • Carrion, R. J., and J. L. Patterson. 2012. An Animal Model That Reflects Human Disease: The Common Marmoset (Callithrix jacchus). Curr. Opin. Virol. 2:357–362. [8] [PMC free article: PMC3378983] [PubMed: 22709521]
  • Castner, S. A., P. S. Goldman-Rakic, and G. V. Williams. 2004. Animal Models of Working Memory: Insights for Targeting Cognitive Dysfunction in Schizophrenia. Psychopharmacology 174(1):111–125. [13] [PubMed: 15205882]
  • Castner, S. A., G. V. Williams, and P. S. Goldman-Rakic. 2000. Reversal of Antipsychotic-Induced Working Memory Deficits by Short-Term Dopamine D1 Receptor Stimulation. Science 287(5460):2020–2022. [13] [PubMed: 10720329]
  • Caughey, B., and P. T. Lansbury. 2003. Protofibrils, Pores, Fibrils, and Neurodegeneration: Separating the Responsible Protein Aggregates from the Innocent Bystanders. Annu. Rev. Neurosci. 26:267–298. [7] [PubMed: 12704221]
  • Ceaser, A. E., T. E. Goldberg, M. F. Egan, et al. 2008. Set-Shifting Ability and Schizophrenia: A Marker of Clinical Illness or an Intermediate Phenotype? Biol. Psychiatry 64:782–788. [12] [PMC free article: PMC3466115] [PubMed: 18597738]
  • Cenik, B., C. F. Sephton, B. Kutluk Cenik, J. Herz, and G. Yu. 2012. Progranulin: A Proteolytically Processed Protein at the Crossroads of Inflammation and Neurodegeneration. J. Biol. Chem. 287(39):32298–32306. [7] [PMC free article: PMC3463300] [PubMed: 22859297]
  • Cepeda, C., L. Galvan, S. M. Holley, et al. 2013. Multiple Sources of Striatal Inhibition Are Differentially Affected in Huntington’s Disease Mouse Models. J. Neurosci. 33:7393–7406. [9] [PMC free article: PMC3686572] [PubMed: 23616545]
  • Chamberlain, S. R., L. Menzies, A. Hampshire, et al. 2008. Orbitofrontal Dysfunction in Patients with Obsessive-Compulsive Disorder and Their Unaffected Relatives. Science 321:421–422. [12] [PubMed: 18635808]
  • Chamberlain, S. R., U. Müller, A. D. Blackwell, et al. 2006. Neurochemical Modulation of Response Inhibition and Probabilistic Learning in Humans. Science 311:861–863. [12] [PMC free article: PMC1867315] [PubMed: 16469930]
  • Chanda, S., S. Marro, M. Wernig, and T. C. Südhof. 2013. Neurons Generated by Direct Conversion of Fibroblasts Reproduce Synaptic Phenotype Caused by Autism-Associated Neuroligin-3 Mutation. PNAS 110:16622–16627. [11] [PMC free article: PMC3799342] [PubMed: 24046374]
  • Chari, S., and I. Dworkin. 2013. The Conditional Nature of Genetic Interactions: The Consequences of Wild-Type Backgrounds on Mutational Interactions in a Genome-Wide Modifier Screen. PLoS Genet. 9(8):e1003661. [2] [PMC free article: PMC3731224] [PubMed: 23935530]
  • Chaudhuri, K. R., D. G. Healy, and A. H. Schapira. 2006. Non-Motor Symptoms of Parkinson’s Disease: Diagnosis and Management. Lancet Neurol. 5(3):235–245. [7] [PubMed: 16488379]
  • Cheeran, B., P. Talelli, F. Mori, et al. 2008. A Common Polymorphism in the Brain-Derived Neurotrophic Factor Gene (BDNF) Modulates Human Cortical Plasticity and the Response to rTMS. J. Physiol. 586:5717–5725. [10] [PMC free article: PMC2655403] [PubMed: 18845611]
  • Chen, H. K., Z. Liu, A. Meyer-Franke, et al. 2012. Small Molecule Structure Correctors Abolish Detrimental Effects of Apolipoprotein E4 in Cultured Neurons. J. Biol. Chem. 287(8):5253–5266. [7] [PMC free article: PMC3285306] [PubMed: 22158868]
  • Chen, P. C., B. J. Bhattacharyya, J. Hanna, et al. 2011. Ubiquitin Homeostasis Is Critical for Synaptic Development and Function. J. Neurosci. 31(48):17505–17513. [5] [PMC free article: PMC3253363] [PubMed: 22131412]
  • Chen, T., K. Koga, G. Descalzi, et al. 2014a. Postsynaptic Potentiation of Corticospinal Projecting Neurons in the Anterior Cingulate Cortex after Nerve Injury. Mol. Pain 10:33. [10] [PMC free article: PMC4060852] [PubMed: 24890933]
  • Chen, T., J. S. Lu, Q. Song, et al. 2014b. Pharmacological Rescue of Cortical Synaptic and Network Potentiation in a Mouse Model for Fragile X Syndrome. Neuropsychopharmacology 39(8):1955–1967. [13] [PMC free article: PMC4059905] [PubMed: 24553731]
  • Chen, T. W., T. J. Wardill, Y. Sun, et al. 2013. Ultrasensitive Fluorescent Proteins for Imaging Neuronal Activity. Nature 499(7458):295–300. [8] [PMC free article: PMC3777791] [PubMed: 23868258]
  • Chen, W. R., S. Lee, K. Kato, et al. 1996. Long-Term Modifications of Synaptic Efficacy in the Human Inferior and Middle Temporal Cortex. PNAS 93:8011–8015. [10] [PMC free article: PMC38866] [PubMed: 8755594]
  • Chiba, A. A., R. P. Kesner, and C. J. Gibson. 1997. Memory for Temporal Order of New and Familiar Spatial Location Sequences: Role of the Medial Prefrontal Cortex. Learn. Mem. 4:311–317. [12] [PubMed: 10706368]
  • Chilian, B., H. Abdollahpour, T. Bierhals, et al. 2013. Dysfunction of SHANK2 and CHRNA7 in a Patient with Intellectual Disability and Language Impairment Supports Genetic Epistasis of the Two Loci. Clin. Genet. 84(6):560–565. [2] [PubMed: 23350639]
  • Chu, C.-P., G.-Y. Zhao, R. Jin, et al. 2014. Properties of 4 Hz Stimulation-Induced Parallel Fiber-Purkinje Cell Presynaptic Long-Term Plasticity in Mouse Cerebellar Cortex in Vivo. Eur. J. Neurosci. 39:1624–1631. [10] [PubMed: 24666426]
  • Chung, K., J. Wallace, S. Y. Kim, et al. 2013. Structural and Molecular Interrogation of Intact Biological Systems. Nature 497(7449):332–337. [8, 10] [PMC free article: PMC4092167] [PubMed: 23575631]
  • Church, D. M., L. Goodstadt, L. W. Hillier, et al. 2009. Lineage-Specific Biology Revealed by a Finished Genome Assembly of the Mouse. PLoS Biol. 7:e1000112. [10] [PMC free article: PMC2680341] [PubMed: 19468303]
  • Churchill, G. A., D. C. Airey, H. Allayee, et al. 2004. The Collaborative Cross, a Community Resource for the Genetic Analysis of Complex Traits. Nat. Genet. 36:1133–1137. [8] [PubMed: 15514660]
  • Clapp, W. C., I. J. Kirk, J. P. Hamm, D. Shepherd, and T. J. Teyler. 2005. Induction of LTP in the Human Auditory Cortex by Sensory Stimulation. Eur. J. Neurosci. 22:1135–1140. [10] [PubMed: 16176355]
  • Clarke, H. F., J. W. Dalley, H. S. Crofts, T. W. Robbins, and A. C. Roberts. 2004. Cognitive Inflexibility after Prefrontal Serotonin Depletion. Science 304:878–880. [12] [PubMed: 15131308]
  • Clavaguera, F., H. Akatsu, G. Fraser, et al. 2013. Brain Homogenates from Human Tauopathies Induce Tau Inclusions in Mouse Brain. PNAS 110(23):9535–9540. [5] [PMC free article: PMC3677441] [PubMed: 23690619]
  • Clavaguera, F., F. Grueninger, and M. Tolnay. 2014a. Intercellular Transfer of Tau Aggregates and Spreading of Tau Pathology: Implications for Therapeutic Strategies. Neuropharmacology 76(Pt A):9–15. [5] [PubMed: 24050961]
  • Clavaguera, F., J. Hench, I. Lavenir, et al. 2014b. Peripheral Administration of Tau Aggregates Triggers Intracerebral Tauopathy in Transgenic Mice. Acta Neuropathol. 1(1):82. [5] [PMC free article: PMC4253855] [PubMed: 24362441]
  • Clayton, N. S., and A. Dickinson. 1998. Episodic-Like Memory During Cache Recovery by Scrub-Jays. Nature 395:272–274. [12] [PubMed: 9751053]
  • Coelho, T., L. F. Maia, A. Martins da Silva, et al. 2012. Tafamidis for Transthyretin Familial Amyloid Polyneuropathy: A Randomized, Controlled Trial. Neurology 79(8):785–792. [7] [PMC free article: PMC4098875] [PubMed: 22843282]
  • Cong, L., F. A. Ran, D. Cox, et al. 2013. Multiplex Genome Engineering Using CRISPR/Cas Systems. Science 339:819–823. [8] [PMC free article: PMC3795411] [PubMed: 23287718]
  • Cooke, S. F., and M. F. Bear. 2012. Stimulus-Selective Response Plasticity in the Visual Cortex: An Assay for the Assessment of Pathophysiology and Treatment of Cognitive Impairment Associated with Psychiatric Disorders. Biol. Psychiatry 71:487–495. [10] [PubMed: 22019003]
  • Cooper, J. J., and F. Ovsiew. 2013. The Relationship between Schizophrenia and Frontotemporal Dementia. J. Geriatr. Psychiatry Neurol. 26(3):131–137. [13] [PubMed: 23733854]
  • Corlett, P. R., G. K. Murray, G. D. Honey, et al. 2007. Disrupted Prediction-Error Signal in Psychosis: Evidence for an Associative Account of Delusions. Brain 130(9):2387–2400. [12] [PMC free article: PMC3838942] [PubMed: 17690132]
  • Corti, S., M. Nizzardo, C. Simone, et al. 2012. Genetic Correction of Human Induced Pluripotent Stem Cells from Patients with Spinal Muscular Atrophy. Sci. Transl. Med. 4:165ra162. [11] [PMC free article: PMC4722730] [PubMed: 23253609]
  • Cosentino, G., B. Fierro, P. Paladino, et al. 2012. Transcranial Direct Current Stimulation Preconditioning Modulates the Effect of High-Frequency Repetitive Transcranial Magnetic Stimulation in the Human Motor Cortex. Eur. J. Neurosci. 35:119–124. [10] [PubMed: 22211744]
  • Costa-Mattioli, M., and L. M. Monteggia. 2013. mTOR Complexes in Neurodevelopmental and Neuropsychiatric Disorders. Nat. Neurosci. 16(11):1537–1543. [2] [PubMed: 24165680]
  • Courtine, G., M. B. Bunge, J. W. Fawcett, et al. 2007. Can Experiments in Nonhuman Primates Expedite the Translation of Treatments for Spinal Cord Injury in Humans? Nat. Med. 13(5):561–566. [13] [PMC free article: PMC3245971] [PubMed: 17479102]
  • Craddock, N., M. C. O’Donovan, and M. J. Owen. 2007. Phenotypic and Genetic Complexity of Psychosis. Invited Commentary on Schizophrenia: A Common Disease Caused by Multiple Rare Alleles. Br. J. Psychiatry 190:200–203. [3] [PubMed: 17329738]
  • Craddock, N., and M. J. Owen. 2005. The Beginning of the End for the Kraepelinian Dichotomy. Br. J. Psychiatry 186:364–366. [3] [PubMed: 15863738]
  • Craddock, N., and M. J. Owen. 2010. The Kraepelinian Dichotomy: Going, Going...But Still Not Gone. Br. J. Psychiatry 196:92–95. [3] [PMC free article: PMC2815936] [PubMed: 20118450]
  • Craddock, N., and P. Sklar. 2013. Genetics of Bipolar Disorder. Lancet 381:1654–1662. [8] [PubMed: 23663951]
  • Cramer, P. E., J. R. Cirrito, D. W. Wesson, et al. 2012. Apoe-Directed Therapeutics Rapidly Clear Beta-Amyloid and Reverse Deficits in AD Mouse Models. Science 335(6075):1503–1506. [7] [PMC free article: PMC3651582] [PubMed: 22323736]
  • Criswell, S. R., J. S. Perlmutter, T. O. Videen, et al. 2011. Reduced Uptake of [18F] FDOPA PET in Asymptomatic Welders with Occupational Manganese Exposure. Neurology 76:1296–1301. [10] [PMC free article: PMC3090062] [PubMed: 21471467]
  • Cross-Disorder Group of the Psychiatric Genomics, C., S. H. Lee, S. Ripke, et al. 2013. Genetic Relationship between Five Psychiatric Disorders Estimated from Genome-Wide SNPs. Nat. Genet. 45(9):984–994. [2, 3] [PMC free article: PMC3800159] [PubMed: 23933821]
  • Cross-Disorder Group of the Psychiatric Genomics Consortium, and Genetic Risk Outcome of Psychosis Consortium. 2013. Identification of Risk Loci with Shared Effects on Five Major Psychiatric Disorders: A Genome-Wide Analysis. Lancet 381(9875):1371–1379. [4] [PMC free article: PMC3714010] [PubMed: 23453885]
  • Cuervo, A. M., and E. Wong. 2013. Chaperone-Mediated Autophagy: Roles in Disease and Aging. Cell Res. 24:92–104. [5] [PMC free article: PMC3879702] [PubMed: 24281265]
  • Cuthbert, B. N. 2014. The RDoC Framework: Facilitating Transition from ICD/DSM to Dimensional Approaches That Integrate Neuroscience and Psychopathology. World Psychiatry 13:28–35. [12] [PMC free article: PMC3918011] [PubMed: 24497240]
  • Cuthbert, B. N., and T. R. Insel. 2013. Toward the Future of Psychiatric Diagnosis: The Seven Pillars of RDoC. BMC Med. 11:126. [3] [PMC free article: PMC3653747] [PubMed: 23672542]
  • Czupryn, A., Y. D. Zhou, X. Chen, et al. 2011. Transplanted Hypothalamic Neurons Restore Leptin Signaling and Ameliorate Obesity in db/db Mice. Science 334:1133–1137. [11] [PMC free article: PMC3770458] [PubMed: 22116886]
  • Dalley, J. W., T. D. Fryer, L. Brichard, et al. 2007. Nucleus Accumbens D2/3 Receptors Predict Trait Impulsivity and Cocaine Reinforcement. Science 315:1267–1270. [12] [PMC free article: PMC1892797] [PubMed: 17332411]
  • Daniels, A. M., A. K. Halladay, A. Shih, L. M. Elder, and G. Dawson. 2014. Approaches to Enhancing the Early Detection of Autism Spectrum Disorders: A Systematic Review of the Literature. J. Am. Acad. Child Adolesc. Psychiatry 53(2):141–152. [4] [PubMed: 24472250]
  • Davies, G., A. Tenesa, A. Payton, et al. 2011. Genome-Wide Association Studies Establish That Human Intelligence Is Highly Heritable and Polygenic. Mol. Psychiatry 16(10):996–1005. [2] [PMC free article: PMC3182557] [PubMed: 21826061]
  • Davis, M., K. Ressler, B. O. Rothbaum, and R. Richardson. 2006. Effects of D-Cycloserine on Extinction: Translation from Preclinical to Clinical Work. Biol. Psychiatry 60:369–375. [12] [PubMed: 16919524]
  • Deary, I. J., J. Yang, G. Davies, et al. 2012. Genetic Contributions to Stability and Change in Intelligence from Childhood to Old Age. Nature 482(7384):212–215. [2] [PubMed: 22258510]
  • de Calignon, A., M. Polydoro, M. Suarez-Calvet, et al. 2012. Propagation of Tau Pathology in a Model of Early Alzheimer’s Disease. Neuron 73(4):685–697. [5] [PMC free article: PMC3292759] [PubMed: 22365544]
  • Deisseroth, K. 2014. Circuit Dynamics of Adaptive and Maladaptive Behaviour. Nature 505(7483):309–317. [13, 14] [PMC free article: PMC4069282] [PubMed: 24429629]
  • Deisseroth, K., and M. J. Schnitzer. 2013. Engineering Approaches to Illuminating Brain Structure and Dynamics. Neuron 80:568–577. [10] [PMC free article: PMC5731466] [PubMed: 24183010]
  • Dell’Mour, V., F. Range, and L. Huber. 2009. Social Learning and Mother’s Behavior in Manipulative Tasks in Infant Marmosets. Am. J. Primatol. 71:503–509. [8] [PubMed: 19319974]
  • DeLong, G. R., C. R. Ritch, and S. Burch. 2002. Fluoxetine Response in Children with Autistic Spectrum Disorders: Correlation with Familial Major Affective Disorder and Intellectual Achievement. Dev. Med. Child Neurol. 44(10):652–659. [4] [PubMed: 12418789]
  • DeLong, G. R., L. A. Teague, and M. McSwain Kamran. 1998. Effects of Fluoxetine Treatment in Young Children with Idiopathic Autism. Dev. Med. Child Neurol. 40(8):551–562. [4] [PubMed: 9746008]
  • Delorme, R., E. Ey, R. Toro, et al. 2013. Progress toward Treatments for Synaptic Defects in Autism. Nat. Med. 19(6):685–694. [2] [PubMed: 23744158]
  • Demeule, M., J. C. Currie, Y. Bertrand, et al. 2008. Involvement of the Low-Density Lipoprotein Receptor-Related Protein in the Transcytosis of the Brain Delivery Vector Angiopep-2. J. Neurochem. 106(4):1534–1544. [7] [PubMed: 18489712]
  • Denny, J. C., L. Nastarache, M. S. Ritchie, et al. 2013. Systematic Comparison of Phenome-Wide Association Study of Electronic Medical Record Data and Genome-Wide Association Study Data. Nat. Biotechnol. 31:1102–1111. [10] [PMC free article: PMC3969265] [PubMed: 24270849]
  • Dere, E., J. P. Huston, and M. A. D. S. Silva. 2007. The Pharmacology, Neuroanatomy and Neurogenetics of One-Trial Object Recognition in Rodents. Neurosci. Biobehav. Res. 31:673–704. [12] [PubMed: 17368764]
  • De Rubeis, S., X. He, A. P. Goldberg, et al. 2014. Synaptic, Transcriptional and Chromatin Genes Disrupted in Autism. Nat. Chem. Biol. 515:209–215. [1] [PMC free article: PMC4402723] [PubMed: 25363760]
  • Developmental Disabilities Monitoring Network Surveillance Year Principal Investigators. 2014. Prevalence of Autism Spectrum Disorder among Children Aged 8 Years: Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2010. MMWR Surveill. Summ. 63(Suppl 2):1–21. [2] [PubMed: 24670961]
  • Dias, R., T. W. Robbins, and A. C. Roberts. 1996. Dissociation in Prefrontal Cortex of Affective and Attentional Shifts. Nature 380:69–72. [12] [PubMed: 8598908]
  • Dickerson, F., C. Stallings, A. Origoni, J. Boronow, and R. Yolken. 2007. Elevated Serum Levels of C-Reactive Protein Are Associated with Mania Symptoms in Outpatients with Bipolar Disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 31(4):952–955. [13] [PubMed: 17391822]
  • Diester, I., M. T. Kaufman, M. Mogri, et al. 2011. An Optogenetic Toolbox Designed for Primates. Nat. Neurosci. 14:387–397. [10, 13] [PMC free article: PMC3150193] [PubMed: 21278729]
  • Di Giorgio, F. P., M. A. Carrasco, M. C. Siao, T. Maniatis, and K. Eggan. 2007. Non-Cell Autonomous Effect of Glia on Motor Neurons in an Embryonic Stem Cell-Based ALS Model. Nature Neurosci. 10:608–614. [11] [PMC free article: PMC3139463] [PubMed: 17435754]
  • Dimitrov, D., Y. He, H. Mutoh, et al. 2007. Engineering and Characterization of an Enhanced Fluorescent Protein Voltage Sensor. PLoS One 2:e440. [10] [PMC free article: PMC1857823] [PubMed: 17487283]
  • Dodart, J. C., R. A. Marr, M. Koistinaho, et al. 2005. Gene Delivery of Human Apolipoprotein E Alters Brain Abeta Burden in a Mouse Model of Alzheimer’s Disease. PNAS 102(4):1211–1216. [7] [PMC free article: PMC544620] [PubMed: 15657137]
  • Dölen, G., and M. F. Bear. 2009. Fragile X Syndrome and Autism: From Disease Model to Therapeutic Targets. J. Neurodev. Disord. 1:133–140. [10, 13] [PMC free article: PMC3164025] [PubMed: 21547712]
  • Dölen, G., A. Darvishzadeh, K. W. Huang, and R. C. Malenka. 2013. Social Reward Requires Coordinated Activity of Nucleus Accumbens Oxytocin and Serotonin. Nature 501:179–184. [10] [PMC free article: PMC4091761] [PubMed: 24025838]
  • Dölen, G., E. Osterweil, B. S. S. Rao, et al. 2007. Correction of Fragile X Syndrome in Mice. Neuron 56:955–962. [10, 13] [PMC free article: PMC2199268] [PubMed: 18093519]
  • Dong, S., S. C. Rogan, and B. L. Roth. 2010. Directed Molecular Evolution of DREADDs: A Generic Approach to Creating Next-Generation Rassls. Nat. Protoc. 5:561–573. [10] [PubMed: 20203671]
  • Doody, R. S., R. Raman, M. Farlow, et al. 2013. A Phase 3 Trial of Semagacestat for Treatment of Alzheimer’s Disease. N. Engl. J. Med. 369(4):341–350. [6] [PubMed: 23883379]
  • Dubois, B., H. H. Feldman, C. Jacova, et al. 2010. Revising the Definition of Alzheimer’s Disease: A New Lexicon. Lancet Neurol. 9(11):1118–1127. [6] [PubMed: 20934914]
  • Dunnett, S. B. 1985. Comparative Effects of Cholinergic Drugs and Lesions of Nucleus Basalis or Fimbria-Fornix on Delayed Matching in Rats. Psychopharmacology 87:357–363. [12] [PubMed: 3936093]
  • Durand, C. M., C. Betancur, T. M. Boeckers, et al. 2007. Mutations in the Gene Encoding the Synaptic Scaffolding Protein SHANK3 Are Associated with Autism Spectrum Disorders. Nat. Genet. 39(1):25–27. [2, 4] [PMC free article: PMC2082049] [PubMed: 17173049]
  • Dutch-Belgian Fragile X Consortium. 1994. Fmr1 Knockout Mice: A Model to Study Fragile X Mental Retardation. Cell 78(1):23–33. [13] [PubMed: 8033209]
  • Eacott, M. J., A. Easton, and A. Zinkivskay. 2005. Recollection in an Episodic-Like Memory Task in the Rat. Memory 12:221–223. [12] [PubMed: 15897259]
  • Eagle, D. M., and T. W. Robbins. 2003. Lesions of the Medial Prefrontal Cortex or Nucleus Accumbens Core Do Not Impair Inhibitory Control in Rats Performing a Stop-Signal Reaction Time Task. Behav. Brain Res. 146:131–144. [12] [PubMed: 14643466]
  • Ebert, A. D., J. Yu, F. F. Rose, Jr., et al. 2009. Induced Pluripotent Stem Cells from a Spinal Muscular Atrophy Patient. Nature 457:277–280. [11] [PMC free article: PMC2659408] [PubMed: 19098894]
  • Eiraku, M., K. Watanabe, M. Matsuo-Takasaki, et al. 2008. Self-Organized Formation of Polarized Cortical Tissues from ESCs and Its Active Manipulation by Extrinsic Signals. Cell Stem Cell 3:519–532. [8] [PubMed: 18983967]
  • Elliott, R., B. J. Sahakian, A. P. McKay, et al. 1996. Neuropsychological Impairments in Unipolar Depression: The Influence of Perceived Failure on Subsequent Performance. Psychol. Med. 26:975–989. [12] [PubMed: 8878330]
  • Emre, M., D. Aarsland, A. Albanese, et al. 2004. Rivastigmine for Dementia Associated with Parkinson’s Disease. N. Engl. J. Med. 351(24):2509–2518. [13] [PubMed: 15590953]
  • Engle, S. J., and D. Puppala. 2013. Integrating Human Pluripotent Stem Cells into Drug Development. Cell Stem Cell 12:669–677. [11] [PubMed: 23746976]
  • Enkel, T., D. Gholizadeh, U. von Bohlen, et al. 2010. Ambiguous Cue Interpretation Is Biased under Stress- and Depression-Like States in Rats. Neuropsychopharmacology 35:1008–1015 [12] [PMC free article: PMC3055368] [PubMed: 20043002]
  • Ennaceur, A., and J. Delacour. 1988. A New One-Trial Test for Neurobiological Studies of Memory in Rats. 1: Behavioral Data. Behav. Brain Res. 31:47–59. [12] [PubMed: 3228475]
  • Ennis, L., and T. Wykes. 2013. Impact of Patient Involvement in Mental Health Research: Longitudinal Study. Br. J. Psychiatry 203(5):381–386. [4] [PubMed: 24029538]
  • Ersche, K. D., P. S. Jones, G. B. Williams, et al. 2012. Abnormal Brain Structure Implicated in Stimulant Drug Addiction. Science 335:601–604. [12] [PubMed: 22301321]
  • Espuny-Camacho, I., K. A. Michelsen, D. Gall, et al. 2013. Pyramidal Neurons Derived from Human Pluripotent Stem Cells Integrate Efficiently into Mouse Brain Circuits in Vivo. Neuron 77:440–456. [11] [PubMed: 23395372]
  • Evenden, J. L. 1999. Varieties of Impulsivity. Psychopharmacology 146:348–361. [12] [PubMed: 10550486]
  • Everitt, B. J., and T. W. Robbins. 1997. Central Cholinergic Systems and Cognition. Annu. Rev. Psychol. 48:649–684. [13] [PubMed: 9046571]
  • Everitt, B. J., and T. W. Robbins. 2005. Neural Systems of Reinforcement for Drug Addiction: From Actions to Habits to Compulsion. Nature Neurosci. 8:1481–1489. [12] [PubMed: 16251991]
  • Ey, E., C. S. Leblond, and T. Bourgeron. 2011. Behavioral Profiles of Mouse Models for Autism Spectrum Disorders. Autism Res. 4(1):5–16. [2] [PubMed: 21328568]
  • Fagan, A. M., M. A. Mintun, R. H. Mach, et al. 2006. Inverse Relation between in Vivo Amyloid Imaging Load and Cerebrospinal Fluid Abeta42 in Humans. Ann. Neurol. 59(3):512–519. [7] [PubMed: 16372280]
  • Fernandez, F., W. Morishita, E. Zuniga, et al. 2007. Pharmacotherapy for Cognitive Impairment in a Mouse Model of Down Syndrome. Nat. Neurosci. 10(4):411–413. [7] [PubMed: 17322876]
  • Fernando, A. B., and T. W. Robbins. 2011. Animal Models of Neuropsychiatric Disorders. Ann. Rev. Clin. Psychol. 7:39–61. [12] [PubMed: 21219191]
  • Figurov, A., L. D. Pozz-Miller, P. Olafsson, T. Wang, and B. Lu. 1996. Regulation of Synaptic Responses to High-Frequency Stimulation and LTP by Neurotrophins in the Hippocampus. Nature 381:706–709. [10] [PubMed: 8649517]
  • Flannick, J., G. Thorleifsson, N. L. Beer, et al. 2014. Loss-of-Function Mutations in Slc30a8 Protect against Type 2 Diabetes. Nat. Genet. 46(4):357–363. [2, 4] [PMC free article: PMC4051628] [PubMed: 24584071]
  • Fontes, A., and U. Lakshmipathy. 2013. Advances in Genetic Modification of Pluripotent Stem Cells. Biotechnol. Adv. 31:994–1001. [8] [PubMed: 23856320]
  • Foust, K. D., E. Nurre, C. L. Montgomery, et al. 2009. Intravascular AAV9 Preferentially Targets Neonatal-Neurons and Adult-Astrocytes in CNS. Nat. Biotechnol. 27:59–65. [10] [PMC free article: PMC2895694] [PubMed: 19098898]
  • Fox, M. D., M. A. Halko, M. C. Eldaief, and A. Pascual-Leone. 2012. Measuring and Manipulating Brain Connectivity with Resting State Functional Connectivity Magnetic Resonance Imaging (fcMRI) and Transcranial Magnetic Stimulation (TMS). Neuroimage 62(4):2232–2243. [13] [PMC free article: PMC3518426] [PubMed: 22465297]
  • Frank, S. A. 2014. Somatic Mosaicism and Disease. Curr. Biol. 24(12):R577–R581. [2] [PubMed: 24937287]
  • Freitas, C., F. Farzan, and A. Pascual-Leone. 2013. Assessing Brain Plasticity across the Lifespan with Transcranial Magnetic Stimulation: Why, How, and What Is the Ultimate Goal? Front. Neurosci. 7:42. [13] [PMC free article: PMC3613699] [PubMed: 23565072]
  • Freund, P., E. Schmidlin, T. Wannier, et al. 2006. NoGo: A-Specific Antibody Treatment Enhances Sprouting and Functional Recovery after Cervical Lesion in Adult Primates. Nat. Med. 12(7):790–792. [13] [PubMed: 16819551]
  • Fritsch, B., J. Reis, K. Martinowich, et al. 2010. Direct Current Stimulation Promotes BDNF-Dependent Synaptic Plasticity: Potential Implications for Motor Learning. Neuron 66:198–204. [10] [PMC free article: PMC2864780] [PubMed: 20434997]
  • Frodl, T., J. Scheuerecker, V. Schoepf, et al. 2011. Different Effects of Mirtazapine and Venlafaxine on Brain Activation: An Open Randomized Controlled fMRI Study. J. Clin. Psychiatry 72:448–457. [10] [PubMed: 20868630]
  • Fromer, M., A. J. Pocklington, D. H. Kavanagh, et al. 2014. De Novo Mutations in Schizophrenia Implicate Synaptic Networks. Nature 506(7487):179–184. [3, 4] [PMC free article: PMC4237002] [PubMed: 24463507]
  • Frost, B., and M. I. Diamond. 2010. Prion-Like Mechanisms in Neurodegenerative Diseases. Nat. Rev. Neurosci. 11(3):155–159. [7] [PMC free article: PMC3648341] [PubMed: 20029438]
  • Fusar-Poli, P., S. Borgwardt, A. Bechdolf, et al. 2013. The Psychosis High-Risk State: A Comprehensive State-of-the-Art Review. JAMA Psychiatry 70(1):107–120. [4] [PMC free article: PMC4356506] [PubMed: 23165428]
  • Gaffan, D., R. C. Saunders, E. A. Gaffan, et al. 1984. Effects of Fornix Transection Upon Associative Memory in Monkeys: Role of the Hippocampus in Learned Action. Q. J. Exp. Psychol. B 36:173–227. [12] [PubMed: 6541361]
  • Gafni, O., L. Weinberger, A. A. Mansour, et al. 2013. Derivation of Novel Human Ground State Naive Pluripotent Stem Cells. Nature 504(7479):282–286. [13] [PubMed: 24172903]
  • Galvan, A., X. Hu, Y. Smith, and T. Wichmann. 2012. In Vivo Optogenetic Control of Striatal and Thalamic Neurons in Non-Human Primates. PLoS One 7:e50808. [10] [PMC free article: PMC3511281] [PubMed: 23226390]
  • Gantois, I., A. S. Pop, C. E. de Esch, et al. 2013. Chronic Administration of AFQ056/Mavoglurant Restores Social Behaviour in Fmr1 Knockout Mice. Behav. Brain Res. 239:72–79. [13] [PubMed: 23142366]
  • Gaskin, P. L., S. P. Alexander, and K. C. Fone. 2014. Neonatal Phencyclidine Administration and Post-Weaning Social Isolation as a Dual-Hit Model of “Schizophrenia-Like” Behaviour in the Rat. Psychopharmacology 231(12):2533–2545. [13] [PubMed: 24402141]
  • Gastambide, F., M. C. Cotel, G. Gilmour, et al. 2012. Selective Remediation of Reversal Learning Deficits in the Neurodevelopmental MAM Model of Schizophrenia by a Novel Mglu5 Positive Allosteric Modulator. Neuropsychopharmacology 37(4):1057–1066. [13] [PMC free article: PMC3280638] [PubMed: 22129780]
  • Gatev, P., and T. Wichmann. 2009. Interactions between Cortical Rhythms and Spiking Activity of Single Basal Ganglia Neurons in the Normal and Parkinsonian State. Cereb. Cortex 19:1330–1344. [9] [PMC free article: PMC2677649] [PubMed: 18842667]
  • Geyer, M. A., K. Krebs-Thomson, D. L. Braff, and N. R. Swerdlow. 2001. Pharmacological Studies of Prepulse Inhibition Models of Sensorimotor Gating Deficits in Schizophrenia: A Decade in Review. Psychopharmacology 156:117–154. [12] [PubMed: 11549216]
  • Gilissen, C., J. Y. Hehir-Kwa, D. T. Thung, et al. 2014. Genome Sequencing Identifies Major Causes of Severe Intellectual Disability. Nature 511(7509):344–347. [2] [PubMed: 24896178]
  • Gillberg, C. 2010. The ESSENCE in Child Psychiatry: Early Symptomatic Syndromes Eliciting Neurodevelopmental Clinical Examinations. Res. Dev. Disabil. 31(6):1543–1551. [2] [PubMed: 20634041]
  • Giovanoli, S., H. Engler, A. Engler, et al. 2013. Stress in Puberty Unmasks Latent Neuropathological Consequences of Prenatal Immune Activation in Mice. Science 339(6123):1095–1099. [13] [PubMed: 23449593]
  • Girirajan, S., J. A. Rosenfeld, B. P. Coe, et al. 2012. Phenotypic Heterogeneity of Genomic Disorders and Rare Copy-Number Variants. N. Engl. J. Med. 367(14):1321–1331. [2] [PMC free article: PMC3494411] [PubMed: 22970919]
  • Girirajan, S., J. A. Rosenfeld, G. M. Cooper, et al. 2010. A Recurrent 16p12.1 Microdeletion Supports a Two-Hit Model for Severe Developmental Delay. Nat. Genet. 42(3):203–209. [2] [PMC free article: PMC2847896] [PubMed: 20154674]
  • Giusti-Rodríguez, P., and P. F. Sullivan. 2013. The Genomics of Schizophrenia: Update and Implications. J. Clin. Invest. 123:4557–4563. [8] [PMC free article: PMC3809776] [PubMed: 24177465]
  • Glass, C. K., K. Saijo, B. Winner, M. C. Marchetto, and F. H. Gage. 2010. Mechanisms Underlying Inflammation in Neurodegeneration. Cell 140(6):918–934. [5] [PMC free article: PMC2873093] [PubMed: 20303880]
  • Goetghebeur, P., and R. Dias. 2008. Comparison of Haloperidol, Risperidone, Sertindole, and Modafinil to Reverse an Attentional Set-Shifting Impairment Following Subchronic Pcp Administration in the Rat: A Back Translational Study. Psychopharmacology 202:202. [12] [PubMed: 18392753]
  • Gokhale, A., J. Larimore, E. Werner, et al. 2012. Quantitative Proteomic and Genetic Analyses of the Schizophrenia Susceptibility Factor Dysbindin Identify Novel Roles of the Biogenesis of Lysosome-Related Organelles Complex 1. J. Neurosci. 32(11):3697–3711. [2] [PMC free article: PMC3313842] [PubMed: 22423091]
  • Golde, T. E., L. S. Schneider, and E. H. Koo. 2011. Anti-Abeta Therapeutics in Alzheimer’s Disease: The Need for a Paradigm Shift. Neuron 69(2):203–213. [6] [PMC free article: PMC3058906] [PubMed: 21262461]
  • Goldman-Rakic, P. S. 1996. The Prefrontal Landscape: Implications of Functional Architecture for Understanding Human Mentation and the Central Executive. In: The Prefrontal Cortex, ed. A. C. Roberts et al., pp. 87–102. Oxford: Oxford Univ. Press. [12] [PubMed: 8941956]
  • Goldman-Rakic, P. S., S. A. Castner, T. H. Svensson, L. J. Siever, and G. V. Williams. 2004. Targeting the Dopamine D1 Receptor in Schizophrenia: Insights for Cognitive Dysfunction. Psychopharmacology 174(1):3–16. [13] [PubMed: 15118803]
  • Goldsworthy, M. R., J. B. Pitcher, and M. C. Ridding. 2012. The Application of Spaced Theta Burst Protocols Induces Long-Lasting Neuroplastic Changes in the Human Motor Cortex. Eur. J. Neurosci. 35:125–134. [10] [PubMed: 22118241]
  • Goodin, D. S., and D. Bates. 2009. Treatment of Early Multiple Sclerosis: The Value of Treatment Initiation after a First Clinical Episode. Mult. Scler. 15(10):1175–1182. [6] [PubMed: 19737851]
  • Gottesman, I. I., and T. D. Gould. 2003. The Endophenotype Concept in Psychiatry: Etymology and Strategic Intentions. Am. J. Psychiatry 160(4):636–645. [12] [PubMed: 12668349]
  • Grabrucker, A. M., M. J. Schmeisser, M. Schoen, and T. M. Boeckers. 2011. Postsynaptic ProSAP/Shank Scaffolds in the Cross-Hair of Synaptopathies. Trends Cell. Biol. 21(10):594–603. [4, 10] [PubMed: 21840719]
  • Gradinaru, V., M. Mogri, K. R. Thompson, J. M. Henderson, and K. Deisseroth. 2009. Optical Deconstruction of Parkinsonian Neural Circuitry. Sci. Transl. Med. 324:354–359. [9] [PMC free article: PMC6744370] [PubMed: 19299587]
  • Graf, T. 2011. Historical Origins of Transdifferentiation and Reprogramming. Cell Stem Cell 9(6):504–516. [13] [PubMed: 22136926]
  • Granger, A. J., and R. A. Nicoll. 2014. Expression Mechanisms Underlying Long-Term Potentiation: A Postsynaptic View, 10 Years on. Philos. Trans. R. Soc. Lond. B 369(1633):20130136. [10] [PMC free article: PMC3843869] [PubMed: 24298139]
  • Grant, S. G., M. C. Marshall, K. L. Page, M. A. Cumiskey, and J. D. Armstrong. 2005. Synapse Proteomics of Multiprotein Complexes: en Route from Genes to Nervous System Diseases. Hum. Mol. Genet. 14(2):R225–R234. [3, 4] [PubMed: 16150739]
  • Gratten, J., N. R. Wray, M. C. Keller, and P. M. Visscher. 2014. Large-Scale Genomics Unveils the Genetic Architecture of Psychiatric Disorders. Nat. Neurosci. 17(6):782–790. [2] [PMC free article: PMC4112149] [PubMed: 24866044]
  • Graves, A. R., S. J. Moore, E. B. Bloss, et al. 2012. Hippocampal Pyramidal Neurons Comprise Two Distinct Cell Types That Are Countermodulated by Metabotropic Receptors. Neuron 76:776–789. [10] [PMC free article: PMC3509417] [PubMed: 23177962]
  • Graybiel, A. M. 2008. Habits, Rituals, and the Evaluative Brain. Annu. Rev. Neurosci. 31:359–387. [8] [PubMed: 18558860]
  • Green, E. K., D. Grozeva, I. Jones, et al. 2010. The Bipolar Disorder Risk Allele at CACNA1C Also Confers Risk of Recurrent Major Depression and of Schizophrenia. Mol. Psychiatry 15(10):1016–1022. [3] [PMC free article: PMC3011210] [PubMed: 19621016]
  • Green, M. F., P. D. Butler, Y. Chen, et al. 2009. Perception Measurement in Clinical Trials of Schizophrenia: Promising Paradigms from CNTRICS. Schizophr. Bull. 35:163–181. [12] [PMC free article: PMC2635893] [PubMed: 19023123]
  • Greicius, M. D. 2008. Resting-State Functional Connectivity in Neuropsychiatric Disorders. Curr. Opin. Neurol. 21:424–430. [10] [PubMed: 18607202]
  • Greicius, M. D., G. Srivastava, A. L. Reiss, and V. Menon. 2004. Default-Mode Network Activity Distinguishes Alzheimer’s Disease from Healthy Aging: Evidence from Functional MRI. PNAS 101(13):4637–4642. [7] [PMC free article: PMC384799] [PubMed: 15070770]
  • Grimm, D., J. S. Lee, L. Wang, et al. 2008. In Vitro and in Vivo Gene Therapy Vector Evolution via Multispecies Interbreeding and Retargeting of Adeno-Associated Viruses. J. Virol. 82:5887–5911. [10] [PMC free article: PMC2395137] [PubMed: 18400866]
  • Grozeva, D., G. Kirov, D. F. Conrad, et al. 2013. Reduced Burden of Very Large and Rare CNVs in Bipolar Affective Disorder. Bipolar Dis. 15(8):893–898. [3] [PubMed: 24127788]
  • Grozeva, D., G. Kirov, D. Ivanov, et al. 2010. Rare Copy Number Variants: A Point of Rarity in Genetic Risk for Bipolar Disorder and Schizophrenia. Arch. Gen. Psychiatry 67:318–327. [3] [PMC free article: PMC4476027] [PubMed: 20368508]
  • Guerreiro, R., A. Wojtas, J. Bras, et al. 2013. TREM2 Variants in Alzheimer’s Disease. N. Engl. J. Med. 368(2):117–127. [7] [PMC free article: PMC3631573] [PubMed: 23150934]
  • Guilfoyle, D. N., S. V. Gerum, J. L. Sanchez, et al. 2013. Functional Connectivity fMRI in Mouse Brain at 7t Using Isoflurane. J. Neurosci. Meth. 214:144–148. [9] [PMC free article: PMC3644382] [PubMed: 23376497]
  • Guilmatre, A., G. Huguet, R. Delorme, and T. Bourgeron. 2014. The Emerging Role of Shank Genes in Neuropsychiatric Disorders. Dev. Neurobiol. 74(2):113–122. [4] [PubMed: 24124131]
  • Gulsuner, S., T. Walsh, A. C. Watts, et al. 2013. Spatial and Temporal Mapping of de Novo Mutations in Schizophrenia to a Fetal Prefrontal Cortical Network. Cell 154:518–529. [10] [PMC free article: PMC3894107] [PubMed: 23911319]
  • Guo, Z., L. Zhang, Z. Wu, et al. 2014. In Vivo Direct Reprogramming of Reactive Glial Cells into Functional Neurons after Brain Injury in an Alzheimer’s Disease Model. Cell Stem Cell 14:188–202. [11] [PMC free article: PMC3967760] [PubMed: 24360883]
  • Gur, R. C., M. E. Calkins, T. D. Satterthwaite, et al. 2014. Neurocognitive Growth Charting in Psychosis Spectrum Youths. JAMA Psychiatry 71(4):366–374. [4] [PubMed: 24499990]
  • Haber, S. N., and B. Knutson. 2010. The Reward Circuit: Linking Primate Anatomy to Human Imaging. Neuropsychopharmacol. Rev.:4–26. [12] [PMC free article: PMC3055449] [PubMed: 19812543]
  • Hacker, C. D., J. S. Perlmutter, S. R. Criswell, B. M. Ances, and A. Z. Snyder. 2012. Resting State Functional Connectivity of the Striatum in Parkinson’s Disease. Brain 135:3699–3711. [9] [PMC free article: PMC3525055] [PubMed: 23195207]
  • Hall, E. L., S. E. Robson, P. G. Morris, and M. J. Brookes. 2013. The Relationship between MEG and fMRI. Neuroimage 102(Pt 1):80–91. [9] [PubMed: 24239589]
  • Hall, F. S., L. S. Wilkinson, T. Humby, et al. 1998. Isolation Rearing in Rats: Pre- and Postsynaptic Changes in Striatal Dopaminergic Systems. Pharmacol. Biochem. Behav. 59(4):859–872. [13] [PubMed: 9586842]
  • Hall, M.-H., G. Taylor, P. Sham, et al. 2011. The Early Auditory Gamma-Band Response Is Heritable and a Putative Endophenotype of Schizophrenia. Schizophr. Bull. 37:778–787. [10] [PMC free article: PMC3122286] [PubMed: 19946013]
  • Hamasaki, M., N. Furuta, A. Matsuda, et al. 2013. Autophagosomes Form at ER-Mitochondria Contact Sites. Nature 495(7441):389–393. [5] [PubMed: 23455425]
  • Han, K., J. L. Holder, Jr., C. P. Schaaf, et al. 2013a. SHANK3 Overexpression Causes Manic-Like Behaviour with Unique Pharmacogenetic Properties. Nature 503(7474):72–77. [2, 4] [PMC free article: PMC3923348] [PubMed: 24153177]
  • Han, X., M. Chen, F. Wang, et al. 2013b. Forebrain Engraftment by Human Glial Progenitor Cells Enhances Synaptic Plasticity and Learning in Adult Mice. Cell Stem Cell 12(3):342–353. [13] [PMC free article: PMC3700554] [PubMed: 23472873]
  • Hanlon, F. M., M. P. Weisend, and D. A. Hamilton. 2006. Impairment on the Hippocampal-Dependent Virtual Morris Water Task in Schizophrenia. Schizophr. Res. 87:67–80. [12] [PubMed: 16844347]
  • Haqqani, A. S., N. Caram-Salas, W. Ding, et al. 2013. Multiplexed Evaluation of Serum and CSF Pharmacokinetics of Brain-Targeting Single-Domain Antibodies Using a NanoLC-SRM-ILIS Method. Molec. Pharm. 10(5):1542–1556. [7] [PubMed: 23150993]
  • Hara, T., K. Nakamura, M. Matsui, et al. 2006. Suppression of Basal Autophagy in Neural Cells Causes Neurodegenerative Disease in Mice. Nature 441(7095):885–889. [5] [PubMed: 16625204]
  • Harding, E. J., E. S. Paul, and M. Mendl. 2004. Animal Behavior: Cognitive Bias and Affective State. Nature 427:312–312. [12] [PubMed: 14737158]
  • Hayden, E. Y., and D. B. Teplow. 2013. Amyloid Beta-Protein Oligomers and Alzheimer’s Disease. Alzheimers Res. Ther. 5(6):60. [7] [PMC free article: PMC3978746] [PubMed: 24289820]
  • Hayhurst, M., A. Wagner, M. Cerletti, A. J. Wagers, and L. L. Rubin. 2012. A Cell-Autonomous Defect in Skeletal Muscle Satellite Cells Expressing Low Levels of Survival of Motor Neuron Protein. Devel. Biol. 368:323–334. [11] [PMC free article: PMC3851302] [PubMed: 22705478]
  • Hayworth, K. J., N. Kasthuri, R. Schalek, and J. W. Lichtman. 2006. Automating the Collection of Ultrathin Serial Sections for Large Volume TEM Reconstructions. Microsc. Microanal. 12(S02):86–87. [8]
  • Heckers, S. 2008. Making Progress in Schizophrenia Research. Schizophr. Bull. 34(4):591–594. [4] [PMC free article: PMC2632461] [PubMed: 18492660]
  • Heiman, M., A. Schaefer, S. Gong, et al. 2008. A Translational Profiling Approach for the Molecular Characterization of CNS Cell Types. Cell 135(4):738–748. [7] [PMC free article: PMC2696821] [PubMed: 19013281]
  • Heiman-Patterson, T. D., R. B. Sher, E. A. Blankenhorn, et al. 2011. Effect of Genetic Background on Phenotype Variability in Transgenic Mouse Models of Amyotrophic Lateral Sclerosis: A Window of Opportunity in the Search for Genetic Modifiers. Amyotroph. Lateral Scler. 12:79–86. [9] [PubMed: 21241159]
  • Helmich, R. C., L. C. Derikx, M. Bakker, et al. 2009. Spatial Remapping of Cortico-Striatal Connectivity in Parkinson’s Disease. Cereb. Cortex 20(5):1175–1186. [9] [PubMed: 19710357]
  • Heneka, M. T., M. P. Kummer, A. Stutz, et al. 2013. NLRP3 Is Activated in Alzheimer’s Disease and Contributes to Pathology in APP/PS1 Mice. Nature 493(7434):674–678. [7] [PMC free article: PMC3812809] [PubMed: 23254930]
  • Hershey, T., K. J. Black, J. L. Carl, and J. S. Perlmutter. 2000. Dopa-Induced Blood Flow Responses in Non-Human Primates. Exp. Neurol. 166:342–349. [9] [PubMed: 11085899]
  • Hertz, N. T., A. Berthet, M. L. Sos, et al. 2013. A Neo-Substrate That Amplifies Catalytic Activity of Parkinson’s-Disease-Related Kinase PINK1. Cell 154(4):737–747. [5] [PMC free article: PMC3950538] [PubMed: 23953109]
  • Hnasko, T. S., F. A. Perez, A. D. Scouras, et al. 2006. Cre Recombinase-Mediated Restoration of Nigrostriatal Dopamine in Dopamine-Deficient Mice Reverses Hypophagia and Bradykinesia. PNAS 103:8858–8863. [10] [PMC free article: PMC1466546] [PubMed: 16723393]
  • Ho, B. C., M. Flaum, W. Hubbard, S. Arndt, and N. C. Andreasen. 2004. Validity of Symptom Assessment in Psychotic Disorders: Information Variance across Different Sources of History. Schizophr. Res. 68(2–3):299–307. [4] [PubMed: 15099611]
  • Hoff, P. 1985. Zum Krankheitsbegriff Bei Emil Kraepelin (Concept of Disease of Emil Kraepelin). Nervenarzt 56(9):510–513. [4] [PubMed: 3908947]
  • Hoffman, S. G., J. Q. Wu, and H. Boettcher. 2013. D-Cycloserine as an Augmentation Strategy for Cognitive Behavioral Therapy of Anxiety Disorders. Biol. Mood Anxiety Disord. 3:11. [12] [PMC free article: PMC3686620] [PubMed: 23768232]
  • Hoischen, A., N. Krumm, and E. E. Eichler. 2014. Prioritization of Neurodevelopmental Disease Genes by Discovery of New Mutations. Nat. Neurosci. 17(6):764–772. [2] [PMC free article: PMC4077789] [PubMed: 24866042]
  • Holland, D., L. K. McEvoy, and A. M. Dale. 2012. Unbiased Comparison of Sample Size Estimates from Longitudinal Structural Measures in ADNI. Hum. Brain Mapping 33(11):2586–2602. [6] [PMC free article: PMC3782292] [PubMed: 21830259]
  • Hollingworth, P., D. Harold, R. Sims, et al. 2011. Common Variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP Are Associated with Alzheimer’s Disease. Nat. Genet. 43(5):429–435. [7] [PMC free article: PMC3084173] [PubMed: 21460840]
  • Holmes, C., D. Boche, D. Wilkinson, et al. 2008. Long-Term Effects of Abeta42 Immunisation in Alzheimer’s Disease: Follow-up of a Randomised, Placebo-Controlled Phase I Trial. Lancet 3372(9634):216–223. [6] [PubMed: 18640458]
  • Holtzman, D. M., J. Herz, and G. Bu. 2012. Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease. Cold Spring Harb. Perspect. Med. 2(3):a006312. [7] [PMC free article: PMC3282491] [PubMed: 22393530]
  • Holtzman, D. M., J. C. Morris, and A. M. Goate. 2011. Alzheimer’s Disease: The Challenge of the Second Century. Sci. Transl. Med. 3(77):77sr71. [6, 7]
  • Hong, L. E., A. Summerfelt, B. D. Mitchell, et al. 2008. Sensory Gating Endophenotype Based on Its Neural Oscillatory Pattern and Heritability Estimate. Arch. Gen. Psychiatry 65:1008–1016. [10] [PMC free article: PMC2774756] [PubMed: 18762587]
  • Hood, L., and S. H. Friend. 2011. Predictive, Personalized, Preventive, Participatory (P4) Cancer Medicine. Nat. Rev. Clin. Oncol. 8(3):184–187. [2] [PubMed: 21364692]
  • Hoon, M., T. Soykan, B. Falkenburger, et al. 2011. Neuroligin-4 Is Localized to Glycinergic Postsynapses and Regulates Inhibition in the Retina. PNAS 108:3053–3058. [10] [PMC free article: PMC3041141] [PubMed: 21282647]
  • Hornykiewicz, O., and W. Birkmayer. 1961. Biochemisch-Pharmakologische Grundlagen für Die Klinische Anwendung Von L-Dioxyphenylalanin Beim Parkinson-Syndrom. Wien Klein. Wochenschr. 73:839–840. [9]
  • Howes, O. D., A. J. Montgomery, M. C. Asselin, et al. 2009. Elevated Striatal Dopamine Function Linked to Prodromal Signs of Schizophrenia. Arch. Gen. Psychiatry 66(1):13–20. [13] [PubMed: 19124684]
  • Howes, O. D., and R. M. Murray. 2014 Schizophrenia: An Integrated Sociodevelopmental-Cognitive Model. Lancet 383(9929):1677–1687. [3] [PMC free article: PMC4127444] [PubMed: 24315522]
  • Hsu, P. D., E. S. Lander, and F. Zhang. 2014. Development and Applications of CRISPR-Cas9 for Genome Engineering. Cell 157:1262–1278. [8] [PMC free article: PMC4343198] [PubMed: 24906146]
  • Huang, Y., and L. Mucke. 2012. Alzheimer Mechanisms and Therapeutic Strategies. Cell 148:1204–1222. [5] [PMC free article: PMC3319071] [PubMed: 22424230]
  • Huber, K. M., S. M. Gallagher, S. T. Warren, and M. F. Bear. 2002. Altered Synaptic Plasticity in a Mouse Model of Fragile X Mental Retardation. PNAS 99(11):7746–7750. [13] [PMC free article: PMC124340] [PubMed: 12032354]
  • Hudry, E., J. Dashkoff, A. D. Roe, et al. 2013. Gene Transfer of Human Apoe Isoforms Results in Differential Modulation of Amyloid Deposition and Neurotoxicity in Mouse Brain. Sci. Transl. Med. 5(212):212ra161. [7] [PMC free article: PMC4334150] [PubMed: 24259049]
  • Huguet, G., E. Ey, and T. Bourgeron. 2013. The Genetic Landscapes of Autism Spectrum Disorders. Annu. Rev. Hum. Genet. 14:191–213. [2, 4] [PubMed: 23875794]
  • Hulme, S. R., O. D. Jones, and W. C. Abraham. 2013. Emerging Roles of Metaplasticity in Behaviour and Disease. Trends Neurosci. 36:353–362. [10] [PubMed: 23602195]
  • Hung, A. Y., K. Futai, C. Sala, et al. 2008. Smaller Dendritic Spines, Weaker Synaptic Transmission, but Enhanced Spatial Learning in Mice Lacking Shank1. J. Neurosci. 28(7):1697–1708. [4] [PMC free article: PMC2633411] [PubMed: 18272690]
  • Hurd, M. D., P. Martorell, A. Delavande, K. J. Mullen, and K. M. Langa. 2013. Monetary Costs of Dementia in the United States. N. Engl. J. Med. 368:1326–1334. [7] [PMC free article: PMC3959992] [PubMed: 23550670]
  • Hutchison, R. M., and S. Everling. 2012. Monkey in the Middle: Why Non-Human Primates Are Needed to Bridge the Gap in Resting-State Investigations. Front. Neuroanat. 6:29. [9] [PMC free article: PMC3405297] [PubMed: 22855672]
  • Hutchison, R. M., T. Womelsdorf, E. A. Allen, et al. 2013. Dynamic Functional Connectivity: Promise, Issues, and Interpretations. Neuroimage 80:360–378. [9] [PMC free article: PMC3807588] [PubMed: 23707587]
  • Hutton, M., C. L. Lendon, P. Rizzu, et al. 1998. Association of Missense and 5′-Splice-Site Mutations in Tau with the Inherited Dementia FTDP-17. Nature 393(6686):702–705. [13] [PubMed: 9641683]
  • Hyman, S. E. 2010. The Diagnosis of Mental Disorders: The Problem of Reification. Annu. Rev. Clin. Psychol. 6:155–179. [3, 14] [PubMed: 17716032]
  • Hyman, S. E. 2012. Revolution Stalled. Transl. Med. 4(155):155cm111. [14] [PubMed: 23052291]
  • Hyman, S. E. 2014. Revitalizing Psychiatric Therapeutics. Neuropsychopharmacology 39: 220–229. [1, 11] [PMC free article: PMC3857646] [PubMed: 24317307]
  • Iadecola, C. 2004. Neurovascular Regulation in the Normal Brain and in Alzheimer’s Disease. Nature Neurosci. 5:347–360. [7] [PubMed: 15100718]
  • Iliff, J. J., M. Wang, Y. Liao, et al. 2012. A Paravascular Pathway Facilitates CSF Flow through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β. Sci. Transl. Med. 4(147):147ra111. [5, 7] [PMC free article: PMC3551275] [PubMed: 22896675]
  • Imaizumi, Y., and H. Okano. 2014. Modeling Human Neurological Disorders with Induced Pluripotent Stem Cells. J. Neurochem. 129:388–399. [8] [PubMed: 24286589]
  • Institute of Medicine. 2013. Neurodegeneration: Exploring Commonalities across Diseases. Workshop Summary. Washington, D.C.: National Academies Press. [5] [PubMed: 24199262]
  • International Schizophrenia Consortium, S. M. Purcell, N. R. Wray, et al. 2009. Common Polygenic Variation Contributes to Risk of Schizophrenia and Bipolar Disorder. Nature 460(7256):748–752. [3] [PMC free article: PMC3912837] [PubMed: 19571811]
  • Ioannidis, J. P. 2005. Why Most Published Research Findings Are False. PloS Med. 2(8):e124. [6] [PMC free article: PMC1182327] [PubMed: 16060722]
  • Iossifov, I., M. Ronemus, D. Levy, et al. 2012. De Novo Gene Disruptions in Children on the Autistic Spectrum. Neuron 74(2):285–299. [2] [PMC free article: PMC3619976] [PubMed: 22542183]
  • Irwin, I., L. E. DeLanney, L. S. Forno, et al. 1990. The Evolution of Nigrostriatal Neurochemical Changes in the MPTP-Treated Squirrel Monkey. Brain Res. 531:242–252. [9] [PubMed: 1981162]
  • Irwin, S. 1968. Comprehensive Observational Assessment: Ia. A Systematic, Quantitative Procedure for Assessing the Behavioral and Physiologic State of the Mouse. Psychopharmacology 13:222–257. [12] [PubMed: 5679627]
  • Jack, C. R., Jr., and D. M. Holtzman. 2013. Biomarker Modeling of Alzheimer’s Disease. Neuron 80(6):1347–1358. [7, 14] [PMC free article: PMC3928967] [PubMed: 24360540]
  • Jamain, S., H. Quach, C. Betancur, et al. 2003. Mutations of the X-Linked Genes Encoding Neuroligins NLGN3 and NLGN4 Are Associated with Autism. Nat. Genet. 34(1):27–29. [2, 4] [PMC free article: PMC1925054] [PubMed: 12669065]
  • Jamain, S., K. Radyushkin, K. Hammerschmidt, et al. 2008. Reduced Social Interaction and Ultrasonic Communication in a Mouse Model of Monogenic Heritable Autism. PNAS 105(5):1710–1715. [2] [PMC free article: PMC2234209] [PubMed: 18227507]
  • Javitt, D. C., A. Shelley, and W. Ritter. 2000. Associated Deficits in Mismatch Negativity Generation and Tone Matching in Schizophrenia. Clin. Neurophysiol. 111:1733–1737. [10] [PubMed: 11018486]
  • Jenner, P. 2003. The Contribution of the MPTP-Treated Primate Model to the Development of New Treatment Strategies for Parkinson’s Disease. Parkinsonism Relat. Disord. 9(3):131–137. [13] [PubMed: 12573867]
  • Jensen, K., J. Call, and M. Tomasello. 2007. Chimpanzees Are Rational Maximizers in an Ultimatum Game. Science 318:108–109. [12] [PubMed: 17916736]
  • Jiang, Y. H., and M. D. Ehlers. 2013. Modeling Autism by Shank Gene Mutations in Mice. Neuron 78(1):8–27. [4] [PMC free article: PMC3659167] [PubMed: 23583105]
  • Johnson, K. A., R. A. Sperling, C. M. Gidicsin, et al. 2013. Florbetapir (F18-AV-45) PET to Assess Amyloid Burden in Alzheimer’s Disease Dementia, Mild Cognitive Impairment, and Normal Aging. Alzheimers Dement. 9(Suppl. 5):S72–S83. [6] [PMC free article: PMC3800236] [PubMed: 23375563]
  • Jones, W., and A. Klin. 2013. Attention to Eyes Is Present but in Decline in 2–6-Month-Old Infants Later Diagnosed with Autism. Nature 504(7480):427–431. [4] [PMC free article: PMC4035120] [PubMed: 24196715]
  • Jonsson, T., J. K. Atwal, S. Steinberg, et al. 2012. A Mutation in APP Protects against Alzheimer’s Disease and Age-Related Cognitive Decline. Nature 488(7409):96–99. [7] [PubMed: 22801501]
  • Jonsson, T., H. Stefansson, S. Steinberg, et al. 2013. Variant of TREM2 Associated with the Risk of Alzheimer’s Disease. N. Engl. J. Med. 368(2):107–116. [7] [PMC free article: PMC3677583] [PubMed: 23150908]
  • Joober, R., N. Schmitz, L. Annable, and P. Boksa. 2012. Publication Bias: What Are the Challenges and Can They Be Overcome? J. Psychiatry Neurosci. 37(3):149–152. [2, 4] [PMC free article: PMC3341407] [PubMed: 22515987]
  • Ju, Y. E., B. P. Lucey, and D. M. Holtzman. 2014. Sleep and Alzheimer Disease Pathology: A Bidirectional Relationship. Nat. Rev. Neurol. 10(2):115–119. [7] [PMC free article: PMC3979317] [PubMed: 24366271]
  • Julkunen, P., L. Säisänen, N. Danner, et al. 2009. Comparison of Navigated and Non-Navigated Transcranial Magnetic Stimulation for Motor Cortex Mapping, Motor Threshold and Motor Evoked Potentials. NeuroImage 44:790–795. [10] [PubMed: 18976714]
  • Jurado, S., D. Goswami, Y. Zhang, et al. 2014. LTP Requires a Unique Postsynaptic Snare Fusion Machinery. Neuron 77:542–558. [10] [PMC free article: PMC3569727] [PubMed: 23395379]
  • Kaale, A., M. W. Fagerland, E. W. Martinsen, and L. Smith. 2014. Preschool-Based Social Communication Treatment for Children with Autism: 12-Month Follow-up of a Randomized Trial. J. Am. Acad. Child Adolesc. Psychiatry 53(2):188–198. [4] [PubMed: 24472253]
  • Kadoshima, T., H. Sakaguchi, T. Nakano, et al. 2013. Self-Organization of Axial Polarity, inside-out Layer Pattern, and Species-Specific Progenitor Dynamics in Human ES Cell-Derived Neocortex. PNAS 110(50):20284–20289. [13] [PMC free article: PMC3864329] [PubMed: 24277810]
  • Kalthoff, D., C. Po, D. Wiedermann, and M. Hoehn. 2013. Reliability and Spatial Specificity of Rat Brain Sensorimotor Functional Connectivity Networks Are Superior under Sedation Compared with General Anesthesia. NMR Biomed. 26:638–650. [9] [PubMed: 23303725]
  • Karimi, M., L. Tian, C. A. Brown, et al. 2013. Validation of Nigrostriatal Positron Emission Tomography Measures: Critical Limits. Ann. Neurol. 73:390–396. [9, 10] [PMC free article: PMC3631302] [PubMed: 23423933]
  • Kawakubo, Y., S. Kamio, T. Nose, et al. 2007. Phonetic Mismatch Negativity Predicts Social Skills Acquisition in Schizophrenia. Psychiatry Res. 152:261–265. [10] [PubMed: 17521744]
  • Kawakubo, Y., and K. Kasai. 2006. Support for an Association between Mismatch Negativity and Social Functioning in Schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 30:1367–1368. [10] [PubMed: 16603302]
  • Kawakubo, Y., K. Kasai, N. Kudo, et al. 2006. Phonetic Mismatch Negativity Predicts Verbal Memory Deficits in Schizophrenia. Neuroreport 17:1043–1046. [10] [PubMed: 16791100]
  • Keeler, J. F., and T. W. Robbins. 2011. Translating Cognition from Animals to Humans. Biochem. Pharmacol. 81:1356–1366. [12] [PubMed: 21219876]
  • Kelleher, R. J., III, and M. F. Bear. 2008. The Autistic Neuron: Troubled Translation? Cell 135(3):401–406. [2] [PubMed: 18984149]
  • Kendell, R. E., J. E. Cooper, A. J. Gourlay, et al. 1971. Diagnostic Criteria of American and British Psychiatrists. Arch. Gen. Psychiatry 25(2):123–130. [4] [PubMed: 5569450]
  • Kendler, K. S. 2006. Reflections on the Relationship between Psychiatric Genetics and Psychiatric Nosology. Am. J. Psychiatry 163(7):1138–1146. [3] [PubMed: 16816216]
  • Kendler, K. S. 2013. What Psychiatric Genetics Has Taught Us About the Nature of Psychiatric Illness and What Is Left to Learn. Mol. Psychiatry 18:1058–1066. [8] [PubMed: 23628988]
  • Kettleborough, R. N., E. M. Busch-Nentwich, S. A. Harvey, et al. 2013. A Systematic Genome-Wide Analysis of Zebrafish Protein-Coding Gene Function. Nature 496:494–497. [8] [PMC free article: PMC3743023] [PubMed: 23594742]
  • Kim, E. J., G. D. Rabinovici, W. W. Seeley, et al. 2007. Patterns of MRI Atrophy in Tau Positive and Ubiquitin Positive Frontotemporal Lobar Degeneration. J. Neurol. Neurosurg. Psychiatry 78:1375–1378. [9] [PMC free article: PMC2095621] [PubMed: 17615169]
  • Kim, J., J. M. Basak, and D. M. Holtzman. 2009. The Role of Apolipoprotein E in Alzheimer’s Disease. Neuron 63(3):287–303. [7] [PMC free article: PMC3044446] [PubMed: 19679070]
  • Kim, J., A. E. Eltorai, H. Jiang, et al. 2012. Anti-apoE Immunotherapy Inhibits Amyloid Accumulation in a Transgenic Mouse Model of Aβ Amyloidosis. J. Exp. Med. 209(12):2149–2156. [7] [PMC free article: PMC3501350] [PubMed: 23129750]
  • Kim, J., H. Jiang, S. Park, et al. 2011. Haploinsufficiency of Human APOE Reduces Amyloid Deposition in a Mouse Model of Amyloid-Beta Amyloidosis. J. Neurosci. 31(49):18007–18012. [7] [PMC free article: PMC3257514] [PubMed: 22159114]
  • Kim, Y. S., and M. W. State. 2014. Recent Challenges to the Psychiatric Diagnostic Nosology: A Focus on the Genetics and Genomics of Neurodevelopmental Disorders. Int. J. Epidemiol. 43(2):465–475. [2] [PMC free article: PMC4047292] [PubMed: 24618187]
  • Kirov, G., A. J. Pocklington, P. Holmans, et al. 2012. De Novo CNV Analysis Implicates Specific Abnormalities of Postsynaptic Signalling Complexes in the Pathogenesis of Schizophrenia. Mol. Psychiatry 17(2):142–153. [3, 4] [PMC free article: PMC3603134] [PubMed: 22083728]
  • Kirov, G., E. Rees, J. T. Walters, et al. 2014. The Penetrance of Copy Number Variations for Schizophrenia and Developmental Delay. Biol. Psychiatry 75(5):378–385. [3, 13] [PMC free article: PMC4229045] [PubMed: 23992924]
  • Kirov, G., D. Rujescu, A. Ingason, et al. 2009. Neurexin 1 (NRXN1) Deletions in Schizophrenia. Schizophr. Bull. 35(5):851–854. [3] [PMC free article: PMC2728827] [PubMed: 19675094]
  • Klapoetke, N. C., Y. Murata, S. S. Kim, et al. 2014. Independent Optical Excitation of Distinct Neural Populations. Nat. Methods 11(3):338–346. [8, 10] [PMC free article: PMC3943671] [PubMed: 24509633]
  • Klei, L., S. J. Sanders, M. T. Murtha, et al. 2012. Common Genetic Variants, Acting Additively, Are a Major Source of Risk for Autism. Mol. Autism 3(1):9. [2] [PMC free article: PMC3579743] [PubMed: 23067556]
  • Kleim, J. A., S. Chan, E. Pringle, et al. 2006. BDNF Val66met Polymorphism Is Associated with Modified Experience-Dependent Plasticity in Human Motor Cortex. Nat. Neurosci. 9:735–737. [10] [PubMed: 16680163]
  • Klumpp, H., D. A. Fitzgerald, and K. L. Phan. 2013. Neural Predictors and Mechanisms of Cognitive Behavioral Therapy on Threat Processing in Social Anxiety Disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 45:83–91. [10] [PMC free article: PMC3951971] [PubMed: 23665375]
  • Klunk, W. E., H. Engler, A. Nordberg, et al. 2004. Imaging Brain Amyloid in Alzheimer’s Disease with Pittsburgh Compound-B. Ann. Neurol. 55(3):306–319. [7] [PubMed: 14991808]
  • Kneeland, R. E., and S. H. Fatemi. 2013. Viral Infection, Inflammation and Schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 42:35–48. [13] [PMC free article: PMC3408569] [PubMed: 22349576]
  • Knox, A., A. Schneider, F. Abucayan, et al. 2012. Feasibility, Reliability, and Clinical Validity of the Test of Attentional Performance for Children (KiTAP) in Fragile X Syndrome (FXS). J. Neurodev. Disord. 4:2. [10] [PMC free article: PMC3374289] [PubMed: 22958782]
  • Koga, H., M. Martinez-Vicente, E. Arias, et al. 2011. Constitutive Upregulation of Chaperone-Mediated Autophagy in Huntington’s Disease. J. Neurosci. 31(50):18492–18505. [5] [PMC free article: PMC3282924] [PubMed: 22171050]
  • Koldamova, R., N. F. Fitz, and I. Lefterov. 2010. The Role of ATP-Binding Cassette Transporter A1 in Alzheimer’s Disease and Neurodegeneration. Biochim. Biophys. Acta 1801(8):824–830. [7] [PMC free article: PMC3712769] [PubMed: 20188211]
  • Komatsu, M., S. Waguri, T. Chiba, et al. 2006. Loss of Autophagy in the Central Nervous System Causes Neurodegeneration in Mice. Nature 441(7095):880–884. [5] [PubMed: 16625205]
  • Kong, A., M. L. Frigge, G. Masson, et al. 2012. Rate of de Novo Mutations and the Importance of Father’s Age to Disease Risk. Nature 488(7412):471–475. [2] [PMC free article: PMC3548427] [PubMed: 22914163]
  • Kordower, J. H., C. W. Olanow, H. B. Dodiya, et al. 2013. Disease Duration and the Integrity of the Nigrostriatal System in Parkinson’s Disease. Brain 136:2419–2431. [10] [PMC free article: PMC3722357] [PubMed: 23884810]
  • Krabbe, G., A. Halle, V. Matyash, et al. 2013. Functional Impairment of Microglia Coincides with Beta-Amyloid Deposition in Mice with Alzheimer-Like Pathology. PLoS One 8(4):e60921. [7] [PMC free article: PMC3620049] [PubMed: 23577177]
  • Kravitz, A. V., B. S. Freeze, P. R. Parker, et al. 2010. Regulation of Parkinsonian Motor Behaviours by Optogenetic Control of Basal Ganglia Circuitry. Nature 466:622–626. [9, 10] [PMC free article: PMC3552484] [PubMed: 20613723]
  • Krezowski, J., D. Knudson, C. Ebeling, et al. 2004. Identification of Loci Determining Susceptibility to the Lethal Effects of Amyloid Precursor Protein Transgene Overexpression. Hum. Mol. Genet. 13(18):1989–1997. [6] [PubMed: 15254013]
  • LaFerla, F. M., and K. N. Green. 2012. Animal Models of Alzheimer Disease. Cold Spring Harb. Perspect. Med. 2(11) [13] [PMC free article: PMC3543097] [PubMed: 23002015]
  • Lambert, J. C., C. A. Ibrahim-Verbaas, D. Harold, et al. 2013. Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease. Nat. Genet. 45:1452–1458. [1, 14] [PMC free article: PMC3896259] [PubMed: 24162737]
  • Lancaster, M. A., M. Renner, C. A. Martin, et al. 2013. Cerebral Organoids Model Human Brain Development and Microcephaly. Nature 501(7467):373–379. [8, 11, 13, 14] [PMC free article: PMC3817409] [PubMed: 23995685]
  • Lang, A. E., S. Gill, N. K. Patel, et al. 2006. Randomized Controlled Trial of Intraputamenal Glial Cell Line-Derived Neurotrophic Factor Infusion in Parkinson Disease. Ann. Neurol. 59(3):459–466. [7] [PubMed: 16429411]
  • Lang, N., H. R. Siebner, D. Ernst, et al. 2004. Preconditioning with Transcranial Direct Current Stimulation Sensitizes the Motor Cortex to Rapid-Rate Transcranial Magnetic Stimulation and Controls the Direction of after-Effects. Biol. Psychiatry 56:634–639. [10] [PubMed: 15522246]
  • Laumonnier, F., F. Bonnet-Brilhault, M. Gomot, et al. 2004. X-Linked Mental Retardation and Autism Are Associated with a Mutation in the NLGN4 Gene, a Member of the Neuroligin Family. Am. J. Hum. Genet. 74(3):552–557. [4] [PMC free article: PMC1182268] [PubMed: 14963808]
  • Lawrie, S. M., B. Olabi, J. Hall, and A. M. McIntosh. 2011. Do We Have Any Solid Evidence of Clinical Utility About the Pathophysiology of Schizophrenia? World Psychiatry 10(1):19–31. [3, 10] [PMC free article: PMC3048512] [PubMed: 21379347]
  • Leblond, C. S., J. Heinrich, R. Delorme, et al. 2012. Genetic and Functional Analyses of SHANK2 Mutations Suggest a Multiple Hit Model of Autism Spectrum Disorders. PLoS Genet. 8(2):e1002521. [2, 4] [PMC free article: PMC3276563] [PubMed: 22346768]
  • LeDoux, J. E. 2000. Emotion Circuits in the Brain. Annu. Rev. Neurosci. 23(1):155–184. [12] [PubMed: 10845062]
  • LeDoux, J. E. 2014. Coming to Terms with Fear. PNAS 111:2871–2878. [8] [PMC free article: PMC3939902] [PubMed: 24501122]
  • Lee, B. H., M. J. Lee, S. Park, et al. 2010. Enhancement of Proteasome Activity by a Small-Molecule Inhibitor of USP14. Nat. Chem. Biol. 467(7312):179–184. [5] [PMC free article: PMC2939003] [PubMed: 20829789]
  • Lee, H.-J., E.-J. Bae, and S.-J. Lee. 2014. Extracellular [Alpha]-Synuclein: A Novel and Crucial Factor in Lewy Body Diseases. Nat. Rev. Neurol. 10(2):92–98. [7] [PubMed: 24468877]
  • Lee, H.-M., P. M. Giguere, and B. L. Roth. 2013. DREADDs: Novel Tools for Drug Discovery and Development. Drug Discov. Today 19:469–473. [10] [PMC free article: PMC4004703] [PubMed: 24184433]
  • Lee, K.-H., L. M. Williams, M. Breakspear, and E. Gordon. 2003. Synchronous Gamma Activity: A Review and Contribution to an Integrative Neuroscience Model of Schizophrenia. Brain Res. Rev. 41:57–78. [10] [PubMed: 12505648]
  • Lee, S. H., T. R. DeCandia, S. Ripke, et al. 2012. Estimating the Proportion of Variation in Susceptibility to Schizophrenia Captured by Common SNPs. Nat. Genet. 44(3):247–250. [3] [PMC free article: PMC3327879] [PubMed: 22344220]
  • Lemon, R. N. 2008. Descending Pathways in Motor Control. Annu. Rev. Neurosci. 31:195–218. [13] [PubMed: 18558853]
  • Lenin, V. I. 1917/1990. Што Делать [What Is to Be Done?], translated by J. Fineberg and G. Hanna. London: Penguin Classics. [1]
  • Leonhard, K., H. Beckmann, and C. H. Cahn, eds. 1999. Classification of Endogenous Psychoses and Their Differentiated Etiology. Heidelberg: Springer. [3]
  • Liang, G., and Y. Zhang. 2013. Genetic and Epigenetic Variations in iPSCs: Potential Causes and Implications for Application. Cell Stem Cell 13:149–159. [11] [PMC free article: PMC3760008] [PubMed: 23910082]
  • Lichtenstein, P., B. H. Yip, C. Björk, et al. 2009. Common Genetic Determinants of Schizophrenia and Bipolar Disorder in Swedish Families: A Population-Based Study. Lancet 373(9659):234–239. [3] [PMC free article: PMC3879718] [PubMed: 19150704]
  • Light, G. A., and D. L. Braff. 2005. Stability of Mismatch Negativity Deficits and Their Relationship to Functional Impairments in Chronic Schizophrenia. Am. J. Psychiatry 162:1741–1743. [10] [PubMed: 16135637]
  • Light, G. A., and R. Näätänen. 2013. Mismatch Negativity Is a Breakthrough Biomarker for Understanding and Treating Psychotic Disorders. PNAS 110:15175–15176. [10] [PMC free article: PMC3780842] [PubMed: 23995447]
  • Lim, A. L., D. A. Taylor, and D. T. Malone. 2012. A Two-Hit Model: Behavioural Investigation of the Effect of Combined Neonatal MK-801 Administration and Isolation Rearing in the Rat. J. Psychopharmacol. 26(9):1252–1264. [13] [PubMed: 22361477]
  • Lim, E. T., S. Raychaudhuri, S. J. Sanders, et al. 2013. Rare Complete Knockouts in Humans: Population Distribution and Significant Role in Autism Spectrum Disorders. Neuron 77(2):235–242. [2] [PMC free article: PMC3613849] [PubMed: 23352160]
  • Lima, S. Q., and G. Miesenböck. 2005. Remote Control of Behavior through Genetically Targeted Photostimulation of Neurons. Cell 121:141–152. [10] [PubMed: 15820685]
  • Lin, J. Y., M. Z. Lin, P. Steinbach, and R. Y. Tsien. 2009. Characterization of Engineered Channelrhodopsin Variants with Improved Properties and Kinetics. Biophys. J. 96:1803–1814. [10] [PMC free article: PMC2717302] [PubMed: 19254539]
  • Ling, S. C., M. Polymenidou, and D. W. Cleveland. 2013. Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis. Neuron 79(3):416–438. [5, 6] [PMC free article: PMC4411085] [PubMed: 23931993]
  • Lipska, B. K., and D. R. Weinberger. 2000. To Model a Psychiatric Disorder in Animals: Schizophrenia as a Reality Test. Neuropsychopharmacology 23(3):223–239. [13] [PubMed: 10942847]
  • Lista, S., F. G. Garaci, M. Ewers, et al. 2014. CSF Abeta1–42 Combined with Neuroimaging Biomarkers in the Early Detection, Diagnosis and Prediction of Alzheimer’s Disease. Alzheimers Dement. 10(3):381–392. [13] [PubMed: 23850330]
  • Liu, G. H., J. Qu, K. Suzuki, et al. 2012. Progressive Degeneration of Human Neural Stem Cells Caused by Pathogenic LRRK2. Nature 491:603–607. [11] [PMC free article: PMC3504651] [PubMed: 23075850]
  • Liu, H., Y. Chen, Y. Niu, et al. 2014. TALEN-Mediated Gene Mutagenesis in Rhesus and Cynomolgus Monkeys. Cell Stem Cell 14:323–328. [8] [PMC free article: PMC4024384] [PubMed: 24529597]
  • Lobb, C. J., A. K. Zaheer, Y. Smith, and D. Jaeger. 2013. In Vivo Electrophysiology of Nigral and Thalamic Neurons in Alpha-Synuclein-Overexpressing Mice Highlights Differences from Toxin-Based Models of Parkinsonism. J. Neurophysiol. 110:2792–2805. [9] [PMC free article: PMC3882812] [PubMed: 24068758]
  • Luo, L., E. Callaway, and K. Svoboda. 2008. Genetic Dissection of Neural Circuits. Neuron 57:634–660. [10] [PMC free article: PMC2628815] [PubMed: 18341986]
  • Lüscher, C., and R. C. Malenka. 2011. Drug-Evoked Synaptic Plasticity in Addiction: From Molecular Changes to Circuit Remodeling. Neuron 69:650–663. [10] [PMC free article: PMC4046255] [PubMed: 21338877]
  • Lustig, C., R. Kozak, M. Sarter, J. W. Young, and T. W. Robbins. 2013. CNTRICS Final Animal Model Task Selection: Control of Attention. Neurosci. Biobehav. Res. 37:2099–2110. [12] [PMC free article: PMC3490036] [PubMed: 22683929]
  • Ma, Y., S. Peng, P. G. Spetsieris, et al. 2012. Abnormal Metabolic Brain Networks in a Nonhuman Primate Model of Parkinsonism. J. Cereb. Blood Flow Metab. 32:633–642. [9] [PMC free article: PMC3318142] [PubMed: 22126913]
  • Mackintosh, N. J. 1983. Conditioning and Associative Learning. Oxford: Oxford Univ. Press. [12]
  • Mahley, R. W., and Y. Huang. 2012. Apolipoprotein E Sets the Stage: Response to Injury Triggers Neuropathology. Neuron 76(5):871–885. [7] [PMC free article: PMC4891195] [PubMed: 23217737]
  • Malaspina, D., M. J. Owen, S. Heckers, et al. 2013. Schizoaffective Disorder in the DSM-5. Schizophr. Res. 150(1):21–25. [3] [PubMed: 23707642]
  • Maldonado, T. A., R. E. Jones, and D. O. Norris. 2002. Intraneuronal Amyloid Precursor Protein (APP) and Appearance of Extracellular Beta-Amyloid Peptide (Abeta) in the Brain of Aging Kokanee Salmon. J. Neurobiol. 53(1):11–20. [6] [PubMed: 12360579]
  • Malhotra, D., and J. Sebat. 2012. CNVs: Harbingers of a Rare Variant Revolution in Psychiatric Genetics. Cell 148(6):1223–1241. [3] [PMC free article: PMC3351385] [PubMed: 22424231]
  • Mali, P., K. M. Esvelt, and G. M. Church. 2013a. Cas9 as a Versatile Tool for Engineering Biology. Nat. Methods 19:957–963. [8] [PMC free article: PMC4051438] [PubMed: 24076990]
  • Mali, P., L. Yang, K. M. Esvelt, et al. 2013b. RNA-Guided Human Genome Engineering via Cas9. Science 339:823–826. [8] [PMC free article: PMC3712628] [PubMed: 23287722]
  • Manabe, T., D. J. Wyllie, D. J. Perkel, and R. A. Nicoll. 1993. Modulation of Synaptic Transmission and Long-Term Potentiation: Effects on Paired Pulse Facilitation and EPSC Variance in the CA1 Region of the Hippocampus. J. Neurophysiol. 70:1451–1459. [10] [PubMed: 7904300]
  • Mandelkow, E. M., and E. Mandelkow. 2012. Biochemistry and Cell Biology of Tau Protein in Neurofibrillary Degeneration. Cold Spring Harb. Perspect. Med. 2(7):a006247. [7] [PMC free article: PMC3385935] [PubMed: 22762014]
  • Manly, J. J. 2008. Critical Issues in Cultural Neuropsychology: Profit from Diversity. Neuropsychol. Rev. 18(3):179–183. [2] [PMC free article: PMC2759971] [PubMed: 18814033]
  • Mantini, D., A. Gerits, K. Nelissen, et al. 2011. Default Mode of Brain Function in Monkeys. J. Neurosci. 31:12954–12962. [9] [PMC free article: PMC3686636] [PubMed: 21900574]
  • Marchetto, M. C., C. Carromeu, A. Acab, et al. 2010. A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells. Cell 143:527–539. [11] [PMC free article: PMC3003590] [PubMed: 21074045]
  • Marie, H., and R. C. Malenka. 2006. Acute in Vivo Expression of Recombinant Proteins in Rat Brain Using Sindbis Virus. In: The Dynamic Synapse: Molecular Methods in Ionotropic Receptor Biology, ed. J. T. Kittler and S. J. Moss. Boca Raton: CRC Press. [10] [PubMed: 21204479]
  • Marshall, M., and J. Rathbone. 2011. Early Intervention for Psychosis. Cochrane Database Syst. Rev. 6:CD004718. [4] [PMC free article: PMC4163966] [PubMed: 21678345]
  • Martin-Ordas, G., D. Haun, and J. Call. 2010. Keeping Track of Time: Evidence for Episodic-Like Memory in Great Apes. Anim. Cogn. 13:331–340. [12] [PMC free article: PMC2822233] [PubMed: 19784852]
  • Maruyama, M., H. Shimada, T. Suhara, et al. 2013. Imaging of Tau Pathology in a Tauopathy Mouse Model and in Alzheimer Patients Compared to Normal Controls. Neuron 79(6):1094–1108. [7] [PMC free article: PMC3809845] [PubMed: 24050400]
  • Masliah, E., E. Rockenstein, I. Veinbergs, et al. 2001. Beta-Amyloid Peptides Enhance Alpha-Synuclein Accumulation and Neuronal Deficits in a Transgenic Mouse Model Linking Alzheimer’s Disease and Parkinson’s Disease. PNAS 98(21):12245–12250. [7] [PMC free article: PMC59799] [PubMed: 11572944]
  • Maxwell, C. R., Y. Liang, B. D. Weightman, et al. 2004. Effects of Chronic Olanzapine and Haloperidol Differ on the Mouse N1 Auditory Evoked Potential. Neuropsychopharmacology 29:739–746. [10] [PubMed: 14735128]
  • Mazur, J. E., and R. J. Herrnstein. 1988. On the Functions Relating Delay, Reinforcer Value, and Behavior. Behav. Brain Sci. 11:690–691. [12]
  • McCarroll, S. A., G. Feng, and S. E. Hyman. 2014. Genome-Scale Neurogenetics: Methodology and Meaning. Nat. Neurosci. 17(6):756–763. [2, 8] [PMC free article: PMC4912829] [PubMed: 24866041]
  • McCarroll, S. A., and S. E. Hyman. 2013. Progress in Genetics of Polygenic Brain Disorders: Significant New Challenges for Neurobiology. Neuron 80:578–587. [8, 14] [PMC free article: PMC4066986] [PubMed: 24183011]
  • McClintock, S. M., C. Freitas, L. Oberman, S. H. Lisanby, and A. Pascual-Leone. 2011. Transcranial Magnetic Stimulation: A Neuroscientific Probe of Cortical Function in Schizophrenia. Biol. Psychiatry 70(1):19–27. [13] [PMC free article: PMC3270326] [PubMed: 21571254]
  • McClure, S. M., D. I. Laibson, G. Loewenstein, and J. D. Cohen. 2004. Separate Neural Systems Value Immediate and Delayed Monetary Rewards. Science 306:503–507. [12] [PubMed: 15486304]
  • McConnell, E. R., M. A. McClain, J. Ross, W. R. Lefew, and T. J. Shafer. 2012. Evaluation of Multi-Well Microelectrode Arrays for Neurotoxicity Screening Using a Chemical Training Set. Neurotoxicology 33:1048–1057. [8] [PMC free article: PMC3721981] [PubMed: 22652317]
  • McFarland, H. F., F. Barkhof, J. Antel, and D. H. Miller. 2002. The Role of MRI as a Surrogate Outcome Measure in Multiple Sclerosis. Mult. Scler. 8(1):40–51. [6] [PubMed: 11936488]
  • McGaugh, J. L., and B. Roozendaal. 2008. Drug Enhancement of Memory Consolidation: Historical Perspective and Neurobiological Implications. Psychopharmacology 202:3–14. [12] [PubMed: 18704369]
  • McGoldrick, P., P. I. Joyce, E. M. Fisher, and L. Greensmith. 2013. Rodent Models of Amyotrophic Lateral Sclerosis. Biochim. Biophys. Acta 1832(9):1421–1436. [6] [PubMed: 23524377]
  • McKhann, G. M., D. S. Knopman, H. Chertkow, et al. 2011. The Diagnosis of Dementia Due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease. Alzheimers Dement. 7(3):263–269. [6] [PMC free article: PMC3312024] [PubMed: 21514250]
  • McTeague, L. M., and P. J. Lang. 2012. The Anxiety Spectrum and the Reflex Physiology of Defense: From Circumscribed Fear to Broad Distress. Depress. Anxiety 29(4):264–281. [4] [PMC free article: PMC3612961] [PubMed: 22511362]
  • Medland, S. E., N. Jahanshad, B. M. Neale, and P. M. Thompson. 2014. Whole-Genome Analyses of Whole-Brain Data: Working within an Expanded Search Space. Nat. Neurosci. 17(6):791–800. [2] [PMC free article: PMC4300949] [PubMed: 24866045]
  • Mehta, D., T. Klengel, K. N. Conneely, et al. 2013. Childhood Maltreatment Is Associated with Distinct Genomic and Epigenetic Profiles in Posttraumatic Stress Disorder. PNAS 110(20):8302–8307. [4] [PMC free article: PMC3657772] [PubMed: 23630272]
  • Mendell, J. T., and E. N. Olson. 2012. Micrornas in Stress Signaling and Human Disease. Cell 148(6):1172–1187. [7] [PMC free article: PMC3308137] [PubMed: 22424228]
  • Merkle, F. T., and K. Eggan. 2013. Modeling Human Disease with Pluripotent Stem Cells: From Genome Association to Function. Cell Stem Cell 12:656–668. [11] [PubMed: 23746975]
  • Meyer-Luehmann, M., T. L. Spires-Jones, C. Prada, et al. 2008. Rapid Appearance and Local Toxicity of Amyloid-Beta Plaques in a Mouse Model of Alzheimer’s Disease. Nature 451(7179):720–724. [7] [PMC free article: PMC3264491] [PubMed: 18256671]
  • Michalon, A., A. Bruns, C. Risterucci, et al. 2014. Chronic Metabotropic Glutamate Receptor 5 Inhibition Corrects Local Alterations of Brain Activity and Improves Cognitive Performance in Fragile X Mice. Biol. Psychiatry 75(3):189–197. [13] [PubMed: 23910948]
  • Michie, P. T. 2001. What Has MMN Revealed About the Auditory System in Schizophrenia? Int. J. Psychophysiol. 42:177–194. [10] [PubMed: 11587775]
  • Michie, P. T., T. W. Budd, J. Todd, et al. 2000. Duration and Frequency Mismatch Negativity in Schizophrenia. Clin. Neurophysiol. 111:1054–1065. [10] [PubMed: 10825713]
  • Miller, C. T., K. Mandel, and X. Wang. 2010. The Communicative Content of the Common Marmoset Phee Call During Antiphonal Calling. Am. J. Primatol. 72:974–980. [8] [PMC free article: PMC3715969] [PubMed: 20549761]
  • Miller, J. D., Y. M. Ganat, S. Kishinevsky, et al. 2013a. Human iPSC-Based Modeling of Late-Onset Disease via Progerin-Induced Aging. Cell Stem Cell 13:691–705. [11, 13] [PMC free article: PMC4153390] [PubMed: 24315443]
  • Miller, T. M., A. Pestronk, W. David, et al. 2013b. An Antisense Oligonucleotide against SOD1 Delivered Intrathecally for Patients with SOD1 Familial Amyotrophic Lateral Sclerosis: A Phase 1, Randomised, First-in-Man Study. Lancet Neurol. 12(5):435–442. [7] [PMC free article: PMC3712285] [PubMed: 23541756]
  • Milton, A. L., and B. J. Everitt. 2012. The Psychological and Neurochemical Mechanisms of Drug Memory Consolidation: Implications for the Treatment of Addiction. Eur. J. Neurosci. 31:2308–2319. [12] [PubMed: 20497475]
  • Ming, G. L., O. Brustle, A. Muotri, et al. 2011. Cellular Reprogramming: Recent Advances in Modeling Neurological Diseases. J. Neurosci. 31(45):16070–16075. [13] [PMC free article: PMC3236609] [PubMed: 22072658]
  • Mingozzi, F., and K. A. High. 2011. Therapeutic in Vivo Gene Transfer for Genetic Disease Using AAV: Progress and Challenges. Nat. Rev. Genet. 12:341–355. [10] [PubMed: 21499295]
  • Mink, J. W. 1996. The Basal Ganglia: Focused Selection and Inhibition of Competing Motor Programs. Prog. Neurobiol. 50:381–425. [9] [PubMed: 9004351]
  • Miocinovic, S., S. Somayajula, S. Chitnis, and J. L. Vitek. 2013. History, Applications, and Mechanisms of Deep Brain Stimulation. JAMA Neurol. 70:163–171. [9] [PubMed: 23407652]
  • Mitsui, K., Y. Tokuzawa, H. Itoh, et al. 2003. The Homeoprotein Nanog Is Required for Maintenance of Pluripotency in Mouse Epiblast and ES Cells. Cell 113(5):631–642. [13] [PubMed: 12787504]
  • Moghaddam, B. 2013. A Mechanistic Approach to Preventing Schizophrenia in At-Risk Individuals. Neuron 78(1):1–3. [13] [PubMed: 23583102]
  • Moore, H., J. D. Jentsch, M. Ghajarnia, M. A. Geyer, and A. A. Grace. 2006. A Neurobehavioral Systems Analysis of Adult Rats Exposed to Methylazoxymethanol Acetate on E17: Implications for the Neuropathology of Schizophrenia. Biol. Psychiatry 60(3):253–264. [13] [PMC free article: PMC3396156] [PubMed: 16581031]
  • Moreno-De-Luca, A., S. M. Myers, T. D. Challman, et al. 2013. Developmental Brain Dysfunction: Revival and Expansion of Old Concepts Based on New Genetic Evidence. Lancet Neurol. 12(4):406–414. [2, 4] [PMC free article: PMC4013791] [PubMed: 23518333]
  • Morfini, G. A., M. Burns, L. I. Binder, et al. 2009. Axonal Transport Defects in Neurodegenerative Diseases. J. Neurosci. 29(41):12776–12786. [5] [PMC free article: PMC2801051] [PubMed: 19828789]
  • Morris, K. V., and J. S. Mattick. 2014. The Rise of Regulatory RNA. Nat. Rev. Genet. 15(6):423–437. [10] [PMC free article: PMC4314111] [PubMed: 24776770]
  • Morris, R. G. M., P. Garrud, J. N. P. Rawlins, and J. O’Keefe. 1982. Place Navigation Impaired in Rats with Hippocampal Lesions. Nature 297:681–683. [12] [PubMed: 7088155]
  • Morrow, E. M., S. Y. Yoo, S. W. Flavell, et al. 2008. Identifying Autism Loci and Genes by Tracing Recent Shared Ancestry. Science 321(5886):218–223. [2] [PMC free article: PMC2586171] [PubMed: 18621663]
  • Moskvina, V., N. Craddock, P. Holmans, et al. 2009. Gene-Wide Analyses of Genome-Wide Association Data Sets: Evidence for Multiple Common Risk Alleles for Schizophrenia and Bipolar Disorder and for Overlap in Genetic Risk. Mol. Psychiatry 14(3):252–260. [3] [PMC free article: PMC3970088] [PubMed: 19065143]
  • Mottron, L. 2011. Changing Perceptions: The Power of Autism. Nature 479(7371):33–35. [2] [PubMed: 22051659]
  • Moulder, K. L., B. J. Snider, S. L. Mills, et al. 2013. Dominantly Inherited Alzheimer Network: Facilitating Research and Clinical Trials. Alzheimers Res. Ther. 5(5):48. [7] [PMC free article: PMC3978584] [PubMed: 24131566]
  • Moussavi, S., S. Chatterji, E. Verdes, et al. 2007. Depression, Chronic Diseases, and Decrements in Health: Results from the World Health Surveys. Lancet 370:851–858. [1] [PubMed: 17826170]
  • Moy, S. S., J. J. Nadler, A. Perez, et al. 2004. Sociability and Preference for Social Novelty in Five Inbred Strains: An Approach to Assess Autistic-Like Behavior in Mice. Genes Brain Behav. 3:287–302. [12] [PubMed: 15344922]
  • Murphy, F. C., B. J. Sahakian, J. S. Rubinsztein, et al. 1999. Emotional Bias and Inhibitory Control Processes in Mania and Depression. Psychol. Med. 29:1307–1321. [12] [PubMed: 10616937]
  • Murray, C. J., T. Vos, R. Lozano, et al. 2012. Disability-Adjusted Life Years (Dalys) for 291 Diseases and Injuries in 21 Regions, 1990–2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196. [1] [PMC free article: PMC6350784] [PubMed: 23245607]
  • Murray, E. A., T. J. Bussey, and L. M. Saksida. 2007. Visual Perception and Memory: A New View of Medial Temporal Lobe Function in Primates and Rodents. Annu. Rev. Neurosci. 30:99–122. [12] [PubMed: 17417938]
  • Murray, R. M., and S. W. Lewis. 1987. Is Schizophrenia a Neurodevelopmental Disorder? Br. Med. J. (Clin. Res. Ed.) 295(6600):681–682. [3, 13] [PMC free article: PMC1247717] [PubMed: 3117295]
  • Musiek, E. S., and D. M. Holtzman. 2012. Origins of Alzheimer’s Disease: Reconciling Cerebrospinal Fluid Biomarker and Neuropathology Data Regarding the Temporal Sequence of Amyloid-Beta and Tau Involvement. Curr. Opin. Neurobiol. 25(6):715–720. [7] [PMC free article: PMC3682920] [PubMed: 23041958]
  • Näätänen, R. 2008. Mismatch Negativity (MMN) as an Index of Central Auditory System Plasticity. Int. J. Audiol. 47(Suppl 2):S16–20. [10] [PubMed: 19012108]
  • Näätänen, R., and S. Kähkönen. 2009. Central Auditory Dysfunction in Schizophrenia as Revealed by the Mismatch Negativity (MMN) and Its Magnetic Equivalent Mmnm: A Review. Int. J. Neuropsychopharmacol. 12:125–135. [10] [PubMed: 18771603]
  • Nader, K., and O. Hardt. 2009. A Single Standard for Memory: The Case for Reconsolidation. Nat. Rev. Neurosci. 10(3):224–234. [12] [PubMed: 19229241]
  • Nader, K., G. E. Schafe, and J. E. L. Doux. 2000. Fear Memories Require Protein Synthesis in the Amygdala for Reconsolidation after Retrieval. Nature 406:722–726. [12] [PubMed: 10963596]
  • Nagai, M., D. B. Re, T. Nagata, et al. 2007. Astrocytes Expressing ALS-Linked Mutated SOD1 Release Factors Selectively Toxic to Motor Neurons. Nat. Neurosci. 10:615–622. [11] [PMC free article: PMC3799799] [PubMed: 17435755]
  • Nagai, T., M. Tada, K. Kirihara, et al. 2013. Mismatch Negativity as a “Translatable” Brain Marker toward Early Intervention for Psychosis: A Review. Front. Psychiatry 4:115. [10] [PMC free article: PMC3779867] [PubMed: 24069006]
  • Naj, A. C., G. Jun, G. W. Beecham, et al. 2011. Common Variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 Are Associated with Late-Onset Alzheimer’s Disease. Nat. Genet. 43(5):436–441. [7] [PMC free article: PMC3090745] [PubMed: 21460841]
  • Nakano, T., S. Ando, N. Takata, et al. 2012. Self-Formation of Optic Cups and Storable Stratified Neural Retina from Human ESCs. Cell Stem Cell 10(6):771–785. [13] [PubMed: 22704518]
  • Neale, B. M., Y. Kou, L. Liu, et al. 2012. Patterns and Rates of Exonic de Novo Mutations in Autism Spectrum Disorders. Nature 485(7397):242–245. [2] [PMC free article: PMC3613847] [PubMed: 22495311]
  • Nelson, E. E., and J. T. Winslow. 2009. Non-Human Primates: Model Animals for Developmental Psychopathology. Neuropsychopharmacology 34(1):90–105. [13] [PubMed: 18800061]
  • Nestler, E. J., E. Gould, H. Manji, et al. 2002. Preclinical Models: Status of Basic Research in Depression. Biol. Psychiatry 52:503–528. [12] [PubMed: 12361666]
  • Neve, R. L., K. A. Neve, E. J. Nestler, and W. A. Carlezon. 2005. Use of Herpes Virus Amplicon Vectors to Study Brain Disorders. Biotechniques 39:381–391. [10] [PubMed: 16206910]
  • Nguyen, H. N., B. Byers, B. Cord, et al. 2011. LRRK2 Mutant iPSC-Derived DA Neurons Demonstrate Increased Susceptibility to Oxidative Stress. Cell Stem Cell 8:267–280. [11] [PMC free article: PMC3578553] [PubMed: 21362567]
  • Nielsen, E. B., M. Lyon, and G. Ellison. 1983. Apparent Hallucinations in Monkeys During around-the Clock Amphetamine for Seven to Fourteen Days: Possible Relevance to Amphetamine Psychosis. J. Nerv. Ment. Disord. 171(4):222–233. [12] [PubMed: 6834023]
  • Niewoehner, J., B. Bohrmann, L. Collin, et al. 2014. Increased Brain Penetration and Potency of a Therapeutic Antibody Using a Monovalent Molecular Shuttle. Neuron 81(1):49–60. [7] [PubMed: 24411731]
  • Nishida, Y., S. Arakawa, K. Fujitani, et al. 2009. Discovery of Atg5/Atg7-Independent Alternative Macroautophagy. Nat. Chem. Biol. 461(7264):654–658. [5] [PubMed: 19794493]
  • Nithianantharajah, J., N. H. Komiyama, A. McKechanie, et al. 2013. Synaptic Scaffold Evolution Generated Components of Vertebrate Cognitive Complexity. Nat. Neurosci. 16:16–24. [12] [PMC free article: PMC4131247] [PubMed: 23201973]
  • Nitsche, M. A., F. Müller-Dahlhaus, W. Paulus, and U. Ziemann. 2012. The Pharmacology of Neuroplasticity Induced by Non-Invasive Brain Stimulation: Building Models for the Clinical Use of CNS Active Drugs. J. Physiol. 590:4641–4662. [10] [PMC free article: PMC3487028] [PubMed: 22869014]
  • Nitsche, M. A., A. Roth, M.-F. Kuo, et al. 2007. Timing-Dependent Modulation of Associative Plasticity by General Network Excitability in the Human Motor Cortex. J. Neurosci. 27:3807–3812. [10] [PMC free article: PMC6672399] [PubMed: 17409245]
  • Niu, Y., B. Shen, Y. Cui, et al. 2014. Generation of Gene-Modified Cynomolgus Monkey via Cas9/RNA-Mediated Gene Targeting in One-Cell Embryos. Cell 156(4):836–843. [6, 8, 13] [PubMed: 24486104]
  • Novarino, G., P. El-Fishawy, H. Kayserili, et al. 2012. Mutations in BCKD-Kinase Lead to a Potentially Treatable Form of Autism with Epilepsy. Science 338(6105):394–397. [2] [PMC free article: PMC3704165] [PubMed: 22956686]
  • Obianyo, O., and K. Ye. 2013. Novel Small Molecule Activators of the Trk Family of Receptor Tyrosine Kinases. Biochim. Biophys. Acta 1834(10):2213–2218. [7] [PMC free article: PMC3602283] [PubMed: 22982231]
  • O’Donovan, M. C., N. Craddock, N. Norton, et al. 2008. Identification of Loci Associated with Schizophrenia by Genome-Wide Association and Follow-Up. Nat. Genet. 40(9):1053–1055. [3] [PubMed: 18677311]
  • Okano, H., K. Hikishima, A. Iriki, and E. Sasaki. 2012. The Common Marmoset as a Novel Animal Model System for Biomedical and Neuroscience Research Applications. Semin. Fetal Neonatal Med. 17:336–340. [8] [PubMed: 22871417]
  • Olanow, C. W., O. Rascol, R. Hauser, et al. 2009. A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson’s Disease. N. Engl. J. Med. 361(13):1268–1278. [6] [PubMed: 19776408]
  • Olton, D. S., and B. C. Paras. 1979. Spatial Memory and Hippocampal Function. Neuropsychologia 17:669–682. [12] [PubMed: 522981]
  • Orenstein, S. J., S. H. Kuo, I. Tasset, et al. 2013. Interplay of LRRK2 with Chaperone-Mediated Autophagy. Nat. Neurosci. 16(4):394–406. [5] [PMC free article: PMC3609872] [PubMed: 23455607]
  • O’Roak, B. J., P. Deriziotis, C. Lee, et al. 2011. Exome Sequencing in Sporadic Autism Spectrum Disorders Identifies Severe de Novo Mutations. Nat. Genet. 43(6):585–589. [2] [PMC free article: PMC3115696] [PubMed: 21572417]
  • O’Roak, B. J., L. Vives, W. Fu, et al. 2012a. Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders. Science 338(6114):1619–1622. [2] [PMC free article: PMC3528801] [PubMed: 23160955]
  • O’Roak, B. J., L. Vives, S. Girirajan, et al. 2012b. Sporadic Autism Exomes Reveal a Highly Interconnected Protein Network of de Novo Mutations. Nature 485(7397):246–250. [2] [PMC free article: PMC3350576] [PubMed: 22495309]
  • Ostergard, T., and J. P. Miller. 2014. Deep Brain Stimulation: New Directions. J. Neurosurg. Sci. 58(4):191–198. [14] [PubMed: 25418273]
  • Oswal, A., P. Brown, and V. Litvak. 2013. Synchronized Neural Oscillations and the Pathophysiology of Parkinson’s Disease. Curr. Opin. Neurol. 26:662–670. [9] [PubMed: 24150222]
  • Owen, M. J. 2011. Is There a Schizophrenia to Diagnose? World Psychiatry 10(1):34–35. [3] [PMC free article: PMC3048507] [PubMed: 21379350]
  • Owen, M. J. 2012a. Implications of Genetic Findings for Understanding Schizophrenia. Schizophr. Bull. 38:904–907. [3, 8] [PMC free article: PMC3446223] [PubMed: 22987847]
  • Owen, M. J. 2012b. Intellectual Disability and Major Psychiatric Disorders: A Continuum of Neurodevelopmental Causality. Br. J. Psychiatry 200:268–269. [3] [PubMed: 22474230]
  • Owen, M. J., M. C. O’Donovan, A. Thapar, and N. Craddock. 2011. Neurodevelopmental Hypothesis of Schizophrenia. Br. J. Psychiatry 198(3):173–175. [3] [PMC free article: PMC3764497] [PubMed: 21357874]
  • Ozden, I., J. Wang, Y. Lu, et al. 2013. A Coaxial Optrode as Multifunction Write-Read Probe for Optogenetic Studies in Non-Human Primates. J. Neurosci. Meth.:142–154. [9] [PMC free article: PMC3789534] [PubMed: 23867081]
  • Ozerdema, A., B. Güntekind, M. I. Atagüne, and E. Başar. 2013. Brain Oscillations in Bipolar Disorder in Search of New Biomarkers. Suppl. Clin. Neurophysiol. 62:207–221. [10] [PubMed: 24053042]
  • Pankevich, D. E., B. M. Altevogt, J. Dunlop, F. H. Gage, and S. E. Hyman. 2014. Improving and Accelerating Drug Development for Nervous System Disorders. Neuron 84:546–553. [1, 14] [PMC free article: PMC4254615] [PubMed: 25442933]
  • Paoletti, P., C. Bellone, and Q. Zhou. 2013. NMDA Receptor Subunit Diversity: Impact on Receptor Properties, Synaptic Plasticity and Disease. Nat. Rev. Neurosci. 14:383–400. [10] [PubMed: 23686171]
  • Parikshak, N. N., R. Luo, A. Zhang, et al. 2013. Integrative Functional Genomic Analyses Implicate Specific Molecular Pathways and Circuits in Autism. Cell 155(5):1008–1021. [2, 10] [PMC free article: PMC3934107] [PubMed: 24267887]
  • Park, C., and A. M. Cuervo. 2013. Selective Autophagy: Talking with the UPS. Cell Biochem. Biophys. 67(1):3–13. [5] [PMC free article: PMC3758803] [PubMed: 23709310]
  • Park, H. J., C. H. Kim, E. S. Park, et al. 2013. Increased GABA-a Receptor Binding and Reduced Connectivity at the Motor Cortex in Children with Hemiplegic Cerebral Palsy: A Multimodal Investigation Using 18F-Fluoroflumazenil PET, Immunohistochemistry, and MR Imaging. J. Nucl. Med. 54:1263–1269. [9] [PubMed: 23785171]
  • Parkinson Study Group. 1989. Effect of Deprenyl on the Progression of Disability in Early Parkinson’s Disease. N. Engl. J. Med. 321(20):1364–1371. [6] [PubMed: 2509910]
  • Parkinson Study Group. 1993. Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson’s Disease. N. Engl. J. Med. 328(3):176–183. [6] [PubMed: 8417384]
  • Pasamanick, B., M. E. Rogers, and A. M. Lilienfeld. 1956. Pregnancy Experience and the Development of Behavior Disorders in Children. Am. J. Psychiatry 112:613–618. [3] [PubMed: 13292548]
  • Paterson, N. E., and A. Markou. 2007. Animal Models and Treatments for Addiction and Deprssion Co-Morbidity. Neurotox. Res. 11:1–32. [12] [PubMed: 17449445]
  • Patil, S. T., L. Zhang, F. Martenyi, et al. 2007. Activation of mGlu2/3 Receptors as a New Approach to Treat Schizophrenia: A Randomized Phase 2 Clinical Trial. Nat. Med. 13(9):1102–1107. [13] [PubMed: 17767166]
  • Paul, B. D., J. I. Sbodio, R. Xu, et al. 2014. Cystathionine γ-Lyase Deficiency Mediates Neurodegeneration in Huntington’s Disease. Nature 508:96–100. [10] [PMC free article: PMC4349202] [PubMed: 24670645]
  • Paulsen, J. S., J. D. Long, C. A. Ross, et al. 2014. Prediction of Manifest Huntington’s Disease with Clinical and Imaging Measures: A Prospective Observational Study. Lancet Neurol. 13(12):1193–1201. [5] [PMC free article: PMC4373455] [PubMed: 25453459]
  • Peca, J., C. Feliciano, J. T. Ting, et al. 2011. Shank3 Mutant Mice Display Autistic-Like Behaviours and Striatal Dysfunction. Nature 472(7344):437–442. [2, 4] [PMC free article: PMC3090611] [PubMed: 21423165]
  • Penn, D. C., and D. J. Povinelli. 2007. On the Lack of Evidence That Non-Human Animals Possess Anything Remotely Resembling a “Theory of Mind.” Philos. Trans. R. Soc. Lond. 362:731–744. [12] [PMC free article: PMC2346530] [PubMed: 17264056]
  • Perkins, D. O. 2006. Review: Longer Duration of Untreated Psychosis Is Associated with Worse Outcome in People with First Episode Psychosis. Evid. Based Ment. Health 9(2):36. [4] [PubMed: 16638885]
  • Perou, R., R. H. Bitsko, S. J. Blumberg, et al. 2013. Mental Health Surveillance among Children: United States, 2005–2011. MMWR Surveill. Summ. 62(Suppl 2):1–35. [2]
  • Perrat, P. N., S. DasGupta, J. Wang, et al. 2013. Transposition-Driven Genomic Heterogeneity in the Drosophila Brain. Science 340(6128):91–95. [5] [PMC free article: PMC3887341] [PubMed: 23559253]
  • Perry, D. C., and B. L. Miller. 2013. Frontotemporal Dementia. Semin. Neurol. 33(4):336–341. [7] [PubMed: 24234354]
  • Petersen, R. C., R. G. Thomas, M. Grundman, et al. 2005. Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment. N. Engl. J. Med. 352(23)::2379–2388. [6] [PubMed: 15829527]
  • Pinto, D., A. T. Pagnamenta, L. Klei, et al. 2010. Functional Impact of Global Rare Copy Number Variation in Autism Spectrum Disorders. Nature 466(7304):368–372. [2] [PMC free article: PMC3021798] [PubMed: 20531469]
  • Poduri, A., G. D. Evrony, X. Cai, and C. A. Walsh. 2013. Somatic Mutation, Genomic Variation, and Neurological Disease. Science 341(6141):1237758. [2] [PMC free article: PMC3909954] [PubMed: 23828942]
  • Poline, J. B., J. L. Breeze, S. Ghosh, et al. 2012. Data Sharing in Neuroimaging Research. Front. Neuroinform. 6:9. [2] [PMC free article: PMC3319918] [PubMed: 22493576]
  • Polymeropoulos, M. H. 2000. Genetics of Parkinson’s Disease. Ann. NY Acad. Sci. 920:28–32. [13] [PubMed: 11193165]
  • Pop, A. S., J. Levenga, C. E. de Esch, et al. 2014. Rescue of Dendritic Spine Phenotype in Fmr1 KO Mice with the mGluR5 Antagonist AFQ056/Mavoglurant. Psychopharmacology 231(6):1227–1235. [13] [PubMed: 23254376]
  • Posner, M. I., and S. E. Petersen. 1990. The Attention System of the Human Brain. Annu. Rev. Neurosci. 13:25–42. [12] [PubMed: 2183676]
  • Posporelis, S., A. Sawa, G. S. Smith, et al. 2014. Promoting Careers in Academic Research to Psychiatry Residents. Acad. Psychiatry 38(2):185–190. [13] [PMC free article: PMC4128627] [PubMed: 24497181]
  • Pouladi, M. A., A. J. Morton, and M. R. Hayden. 2013. Choosing an Animal Model for the Study of Huntington’s Disease. Nat. Rev. Neurosci. 14(10):708–721. [6] [PubMed: 24052178]
  • Pouladi, M. A., L. M. Stanek, Y. Xie, et al. 2012. Marked Differences in Neurochemistry and Aggregates Despite Similar Behavioural and Neuropathological Features of Huntington Disease in the Full-Length Bachd and Yac128 Mice. Hum. Mol. Genet. 21:2219–2232. [9] [PubMed: 22328089]
  • Preuss, T. M. 1995. Do Rats Have Prefrontal Cortex? The Rose-Woolsey-Akert Program Reconsidered. J. Cogn. Neurosci. 7:1–24. [8] [PubMed: 23961750]
  • Pringle, A., M. Browning, P. J. Cowen, and C. J. Harmer. 2011. A Cognitive Neuropsychological Model of Antidepressant Drug Action. Prog. Neuropsychopharmacol. Biol. Psychiatry 35:1586–1592. [12] [PubMed: 20673783]
  • Prinz, F., T. Schlange, and K. Asadullah. 2011a. Believe It or Not: How Much Can We Rely on Published Data on Potential Drug Targets? Nat. Rev. Drug Discov. 10(9):712. [6] [PubMed: 21892149]
  • Prinz, M., J. Priller, S. S. Sisodia, and R. M. Ransohoff. 2011b. Heterogeneity of CNS Myeloid Cells and Their Roles in Neurodegeneration. Nat. Neurosci. 14(10):1227–1235. [7] [PubMed: 21952260]
  • Purcell, S. M., J. L. Moran, M. Fromer, et al. 2014. A Polygenic Burden of Rare Disruptive Mutations in Schizophrenia. Nature 506(7487):185–190. [3, 4] [PMC free article: PMC4136494] [PubMed: 24463508]
  • Raby, C. R., D. M. Alexis, A. Dickinson, and N. S. Clayton. 2007. Planning for the Future by Western Scrub-Jays. Nature 445:919–921. [10] [PubMed: 17314979]
  • Racette, B. A., L. Good, J. A. Antenor, et al. 2006. [18F]FDOPA PET as an Endophenotype for Parkinson’s Disease Linkage Studies. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141:245–249. [9] [PMC free article: PMC2646004] [PubMed: 16528749]
  • Rafii, M. S., T. L. Baumann, R. A. Bakay, et al. 2014. A Phase1 Study of Stereotactic Gene Delivery of AAV2-NGF for Alzheimer’s Disease. Alzheimers Dement. [7] [PubMed: 24411134]
  • Ramaswami, M., J. P. Taylor, and R. Parker. 2013. Altered Ribostasis: RNA-Protein Granules in Degenerative Disorders. Cell 154(4):727–736. [5] [PMC free article: PMC3811119] [PubMed: 23953108]
  • Ramocki, M. B., and H. Y. Zoghbi. 2008. Failure of Neuronal Homeostasis Results in Common Neuropsychiatric Phenotypes. Nature 455(7215):912–918. [2] [PMC free article: PMC2696622] [PubMed: 18923513]
  • Ran, F. A., P. D. Hsu, J. Wright, et al. 2013. Genome Engineering Using the CRISPR-Cas9 System. Nat. Protoc. 8:2281–2308. [10] [PMC free article: PMC3969860] [PubMed: 24157548]
  • Ravina, B., D. Eidelberg, J. E. Ahlskog, et al. 2005. The Role of Radiotracer Imaging in Parkinson Disease. Neurology 64:208–215. [9] [PubMed: 15668415]
  • Reardon, S. 2014. NIH Rethinks Psychiatry Trials. Nature 507(7492):288. [4] [PubMed: 24646977]
  • Rees, E., J. T. Walters, L. Georgieva, et al. 2014. Analysis of Copy Number Variations at 15 Schizophrenia-Associated Loci. Br. J. Psychiatry 204(2):108–114. [3] [PMC free article: PMC3909838] [PubMed: 24311552]
  • Regier, D. A., W. E. Narrow, D. E. Clarke, et al. 2013. DSM-5 Field Trials in the United States and Canada, Part II: Test-Retest Reliability of Selected Categorical Diagnoses. Am. J. Psychiatry 170(1):59–70. [4] [PubMed: 23111466]
  • Reilly, M. T., G. J. Faulkner, J. Dubnau, I. Ponomarev, and F. H. Gage. 2013. The Role of Transposable Elements in Health and Diseases of the Central Nervous System. J. Neurosci. 33(45):17577–17586. [5] [PMC free article: PMC3818539] [PubMed: 24198348]
  • Reiman, E. M., J. B. Langbaum, A. S. Fleisher, et al. 2011. Alzheimer’s Prevention Initiative: A Plan to Accelerate the Evaluation of Presymptomatic Treatments. J. Alzheimer. Dis. 26(Suppl. 3):321–329. [6] [PMC free article: PMC3343739] [PubMed: 21971471]
  • Riley, B. E., S. J. Gardai, D. Emig-Agius, et al. 2014. Systems-Based Analyses of Brain Regions Functionally Impacted in Parkinson’s Disease Reveals Underlying Causal Mechanisms. PLoS One 9(8):e102909. [14] [PMC free article: PMC4149353] [PubMed: 25170892]
  • Ripke, S., C. O’Dushlaine, K. Chambert, et al. 2013. Genome-Wide Association Analysis Identifies 13 New Risk Loci for Schizophrenia. Nat. Genet. 45(10, 13):1150–1159. [3, 4, 13] [PMC free article: PMC3827979] [PubMed: 23974872]
  • Rissling, A. J., S. Makeig, D. L. Braff, and G. A. Light. 2010. Neurophysiologic Markers of Abnormal Brain Activity in Schizophrenia. Curr. Psychiatry Rep. 12:572–578. [10] [PMC free article: PMC2965365] [PubMed: 20857348]
  • Rissling, A. J., S.-H. Park, J. W. Young, et al. 2013. Demand and Modality of Directed Attention Modulate “Pre-Attentive” Sensory Processes in Schizophrenia Patients and Nonpsychiatric Controls. Schizophr. Res. 146:326–335. [10] [PMC free article: PMC3622836] [PubMed: 23490760]
  • Robbins, T. W. 2002. The 5-Choice Serial Reaction Time Task: Behavioral Pharmacology and Functional Neurochemistry. Psychopharmacology 163:362–380. [12] [PubMed: 12373437]
  • Robbins, T. W. 2014. The Neuropsychopharmacology of Attention. In: The Handbook of Attention, ed. K. Nobre and S. Kastner, pp. 509–541. Oxford: Oxford Univ. Press. [12]
  • Robbins, T. W., and A. F. Arnsten. 2009. The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation. Annu. Rev. Neurosci. 32:267–287. [13] [PMC free article: PMC2863127] [PubMed: 19555290]
  • Robins, E., and S. B. Guze. 1970. Establishment of Diagnostic Validity in Psychiatric Illness: Its Application to Schizophrenia. Am. J. Psychiatry 126:983–987. [3] [PubMed: 5409569]
  • Robinson, E. S. J., D. M. Eagle, A. C. Mar, et al. 2008. Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat. Neuropsychopharmacology 33:1028–1037. [12] [PubMed: 17637611]
  • Robinson, R. G., K. L. Kubos, L. B. Starr, K. Rao, and T. R. Price. 1984. Mood Disorders in Stroke Patients. Importance of Location of Lesion. Brain 107(Pt 1):81–93. [13] [PubMed: 6697163]
  • Rodriguez-Navarro, J. A., S. Kaushik, H. Koga, et al. 2012. Inhibitory Effect of Dietary Lipids on Chaperone-Mediated Autophag. PNAS 109(12):E705–714. [5] [PMC free article: PMC3311383] [PubMed: 22331875]
  • Romberg, C., M. P. Mattson, M. R. Mughal, T. J. Bussey, and L. M. Saksida. 2011. Impaired Attention in the 3xTgAD Mouse Model of Alzheimer’s Disease: Rescue by Donepezil (Aricept). J. Neurosci. 31(9):3500–3507. [13] [PMC free article: PMC3066152] [PubMed: 21368062]
  • Rosen, R. F., A. S. Farberg, M. Gearing, et al. 2008. Tauopathy with Paired Helical Filaments in an Aged Chimpanzee. J. Comp. Neurol. 509(3):259–270. [6] [PMC free article: PMC2573460] [PubMed: 18481275]
  • Rosin, B., M. Slovik, R. Mitelman, et al. 2011. Closed-Loop Deep Brain Stimulation Is Superior in Ameliorating Parkinsonism. Neuron 72(2):370–384. [13] [PubMed: 22017994]
  • Ross, C. A., E. H. Aylward, E. J. Wild, et al. 2014. Huntington Disease: Natural History, Biomarkers and Prospects for Therapeutics. Nat. Rev. Neurol. 10(4):204–216. [13] [PubMed: 24614516]
  • Ross, R. M., N. A. McNair, S. L. Fairhall, et al. 2008. Induction of Orientation-Specific LTP-Like Changes in Human Visual Evoked Potentials by Rapid Sensory Stimulation. Brain Res. Bull. 76:97–101. [10] [PubMed: 18395617]
  • Rossi, S., M. Hallett, P. M. Rossini, and A. Pascual-Leone. 2009. Safety, Ethical Considerations, and Application Guidelines for the Use of Transcranial Magnetic Stimulation in Clinical Practice and Research. Clin. Neurophysiol. 120:2008–2039. [10] [PMC free article: PMC3260536] [PubMed: 19833552]
  • Rossini, P. M., S. Rossi, C. Babiloni, and J. Polich. 2007. Clinical Neurophysiology of Aging Brain: From Normal Aging to Neurodegeneration. Prog. Neurobiol. 83:375–400. [9] [PubMed: 17870229]
  • Rosti, R. O., A. A. Sadek, K. K. Vaux, and J. G. Gleeson. 2014. The Genetic Landscape of Autism Spectrum Disorders. Dev. Med. Child Neurol. 56:12–18. [8] [PubMed: 24116704]
  • Roth, G. S., J. A. Mattison, M. A. Ottinger, et al. 2004. Aging in Rhesus Monkeys: Relevance to Human Health Interventions. Science 305(5689):1423–1426. [13] [PubMed: 15353793]
  • Rothkegel, H., M. Sommer, and W. Paulus. 2010. Breaks During 5 Hz rTMS Are Essential for Facilitatory after Effects. Clin. Neurophysiol. 121:426–430. [10] [PubMed: 20006546]
  • Rubin, L. L. 2008. Stem Cells and Drug Discovery: The Beginning of a New Era? Cell 132:549–552. [11] [PubMed: 18295572]
  • Ruderfer, D. M., A. H. Fanous, S. Ripke, et al. 2013. Polygenic Dissection of Diagnosis and Clinical Dimensions of Bipolar Disorder and Schizophrenia. Mol. Psychiatry 19(9):1017–1024. [3] [PMC free article: PMC4033708] [PubMed: 24280982]
  • Rutter, M., J. Kim-Cohen, and B. Maughan. 2006. Continuities and Discontinuities in Psychopathology between Childhood and Adult Life. J. Child Psychol. Psychiatry 47(3–4): 276–295. [3] [PubMed: 16492260]
  • Ryan, S. D., N. Dolatabadi, S. F. Chan, et al. 2013. Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1alpha Transcription. Cell 155(6):1351–1364. [5] [PMC free article: PMC4028128] [PubMed: 24290359]
  • Sahakian, B. J., A. M. Owen, N. J. Morant, et al. 1993. Further Analysis of the Cognitive Effects of Tetrahydroaminoacridine (THA) in Alzheimer’s Disease: Assessment of Attentional and Mnemonic Function Using CANTAB. Psychopharmacology 110:395–401. [12, 13] [PubMed: 7870908]
  • Sahakian, K., and R. Jaenisch. 2009. Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease. Cell Stem Cell 5(6):584–595. [13] [PMC free article: PMC2921621] [PubMed: 19951687]
  • Salinas, S., G. Schiavo, and E. J. Kremer. 2010. A Hitchhiker’s Guide to the Nervous System: The Complex Journey of Viruses and Toxins. Nat. Rev. Microbiol. 8:645–655. [10] [PubMed: 20706281]
  • Salloway, S., R. Sperling, and H. R. Brashear. 2014a. Phase 3 Trials of Solanezumab and Bapineuzumab for Alzheimer’s Disease. N. Engl. J. Med. 370(15):1460. [7] [PubMed: 24724181]
  • Salloway, S., R. Sperling, N. C. Fox, et al. 2014b. Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer’s Disease. N. Engl. J. Med. 370(4):322–333. [6] [PMC free article: PMC4159618] [PubMed: 24450891]
  • Sanchez, P. E., L. Zhu, L. Verret, et al. 2012. Levetiracetam Suppresses Neuronal Network Dysfunction and Reverses Synaptic and Cognitive Deficits in an Alzheimer’s Disease Model. PNAS 109(42):E2895–2903. [7] [PMC free article: PMC3479491] [PubMed: 22869752]
  • Sanders, S. J., A. G. Ercan-Sencicek, V. Hus, et al. 2011. Multiple Recurrent de Novo CNVs, Including Duplications of the 7q11.23 Williams Syndrome Region, Are Strongly Associated with Autism. Neuron 70(5):863–885. [2] [PMC free article: PMC3939065] [PubMed: 21658581]
  • Sanders, S. J., M. T. Murtha, A. R. Gupta, et al. 2012. De Novo Mutations Revealed by Whole-Exome Sequencing Are Strongly Associated with Autism. Nature 485(7397):237–241. [2] [PMC free article: PMC3667984] [PubMed: 22495306]
  • SantaCruz, K., J. Lewis, T. Spires, et al. 2005. Tau Suppression in a Neurodegenerative Mouse Model Improves Memory Function. Science 309(5733):476–481. [6] [PMC free article: PMC1574647] [PubMed: 16020737]
  • Sasai, Y. 2013. Next-Generation Regenerative Medicine: Organogenesis from Stem Cells in 3D Culture. Cell Stem Cell 12:520–530. [11] [PubMed: 23642363]
  • Sasaki, E., H. Suemizu, A. Shimada, et al. 2009. Generation of Transgenic Non-Human Primates with Germline Transmission. Nature 459(7246):523–527. [6, 13] [PubMed: 19478777]
  • Sato, D., A. C. Lionel, C. S. Leblond, et al. 2012. Shank1 Deletions in Males with Autism Spectrum Disorder. Am. J. Hum. Genet. 90(5):879–887. [4] [PMC free article: PMC3376495] [PubMed: 22503632]
  • Schafer, D. P., E. K. Lehrman, A. G. Kautzman, et al. 2012. Microglia Sculpt Postnatal Neural Circuits in an Activity and Complement-Dependent Manner. Neuron 74(4):691–705. [7] [PMC free article: PMC3528177] [PubMed: 22632727]
  • Schiel, N., and L. Huber. 2006. Social Influences on the Development of Foraging Behavior in Free-Living Common Marmosets (Callithrix jacchus). Am. J. Primatol. 68:1150–1160. [8] [PubMed: 16900507]
  • Schizophrenia Working Group of the Psychiatric Genomics Consortium. 2014. Biological Insights from 108 Schizophrenia-Associated Genetic Loci. Nature 511:421–427. [1, 3, 10] [PMC free article: PMC4112379] [PubMed: 25056061]
  • Schmeisser, M. J., E. Ey, S. Wegener, et al. 2012. Autistic-Like Behaviours and Hyperactivity in Mice Lacking ProSAP1/Shank2. Nature 486(7402):256–260. [2, 4] [PubMed: 22699619]
  • Schmiedt, C., A. Brand, H. Hildebrandt, and C. Basar-Eroglu. 2005. Event-Related Theta Oscillations During Working Memory Tasks in Patients with Schizophrenia and Healthy Controls. Cogn. Brain Res. 25:936–947. [10] [PubMed: 16289526]
  • Schneider, J. S., E. Y. Pioli, Y. Jianzhong, Q. Li, and E. Bezard. 2013. Levodopa Improves Motor Deficits but Can Further Disrupt Cognition in a Macaque Parkinson Model. Mov. Disord. 28:663–667. [9] [PubMed: 23238827]
  • Schneider, J. S., G. Unguez, A. Yuwiler, S. C. Berg, and C. H. Markham. 1988. Deficits in Operant Behaviour in Monkeys Treated with N-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP). Brain 111(Pt 6):1265–1285. [9] [PubMed: 3264739]
  • Schrijvers, E. M., B. F. Verhaaren, P. J. Koudstaal, et al. 2012. Is Dementia Incidence Declining? Trends in Dementia Incidence since 1990 in the Rotterdam Study. Neurology 78(19):1456–1463. [7] [PubMed: 22551732]
  • Schultz, W., and A. Dickinson. 2000. Neuronal Coding of Prediction Errors. Annu. Rev. Neurosci. 23:473–500. [12] [PubMed: 10845072]
  • Schwab, M. E. 2004. Nogo and Axon Regeneration. Curr. Opin. Neurobiol. 14(1):118–124. [13] [PubMed: 15018947]
  • Schwarz, S., L. Froelich, and A. Burns. 2012. Pharmacological Treatment of Dementia. Curr. Opin. Psychiatry 25(6):542–550. [13] [PubMed: 22992546]
  • Sekar, S., E. Jonckers, M. Verhoye, et al. 2013. Subchronic Memantine Induced Concurrent Functional Disconnectivity and Altered Ultra-Structural Tissue Integrity in the Rodent Brain: Revealed by Multimodal MRI. Psychopharmacology 227:479–491. [9] [PubMed: 23354531]
  • Seminowicz, D. A., H. S. Mayberg, A. R. McIntosh, et al. 2004. Limbic-Frontal Circuitry in Major Depression: A Path Modeling Metanalysis. NeuroImage 22:409–418. [10] [PubMed: 15110034]
  • Seok, J., H. S. Warren, A. G. Cuenca, et al. 2013. Inflammation and Host Response to Injury, Large Scale Collaborative Research Program. Genomic Responses in Mouse Models Poorly Mimic Human Inflammatory Diseases. PNAS 110:3507–3512. [11] [PMC free article: PMC3587220] [PubMed: 23401516]
  • Serio, A., B. Bilican, S. J. Barmada, et al. 2013. Astrocyte Pathology and the Absence of Non-Cell Autonomy in an Induced Pluripotent Stem Cell Model of TDP-43 Proteinopathy. PNAS 110(12):4697–4702. [5] [PMC free article: PMC3607024] [PubMed: 23401527]
  • Shafi, M. M., M. B. Westover, M. D. Fox, and A. Pascual-Leone. 2012. Exploration and Modulation of Brain Network Interactions with Noninvasive Brain Stimulation in Combination with Neuroimaging. Eur. J. Neurosci. 35(6):805–825. [13] [PMC free article: PMC3313459] [PubMed: 22429242]
  • Shao, K., R. Huang, J. Li, et al. 2010. Angiopep-2 Modified PE-PEG Based Polymeric Micelles for Amphotericin B Delivery Targeted to the Brain. J. Control Release 147(1):118–126. [7] [PubMed: 20609375]
  • Sharma, K., S. Y. Choi, Y. Zhang, et al. 2013. High-Throughput Genetic Screen for Synaptogenic Factors: Identification of LRP6 as Critical for Excitatory Synapse Development. Cell Rep. 5:1330–1341. [8] [PMC free article: PMC3924421] [PubMed: 24316074]
  • Shay, T., V. Jojic, O. Zuk, et al. 2013. Conservation and Divergence in the Transcriptional Programs of the Human and Mouse Immune Systems. PNAS 110(8):2946–2951. [6] [PMC free article: PMC3581886] [PubMed: 23382184]
  • Shcheglovitov, A., O. Shcheglovitova, M. Yazawa, et al. 2013. SHANK3 and IGF1 Restore Synaptic Deficits in Neurons from 22q13 Deletion Syndrome Patients. Nature 503(7475):267–271. [2, 4, 11] [PMC free article: PMC5559273] [PubMed: 24132240]
  • Sheline, Y. I., M. E. Raichle, A. Z. Snyder, et al. 2010. Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly. Biol. Psychiatry 67:584–587. [9] [PMC free article: PMC2829379] [PubMed: 19833321]
  • Sidorov, M. S., B. D. Auerbach, and M. F. Bear. 2013. Fragile X Mental Retardation Protein and Synaptic Plasticity. Mol. Brain 6:15. [10] [PMC free article: PMC3636002] [PubMed: 23566911]
  • Siebner, H. R., T. O. Bergmann, S. Bestmann, et al. 2009. Consensus Paper: Combining Transcranial Stimulation with Neuroimaging. Brain Stimul. 2:58–80. [10] [PubMed: 20633405]
  • Siegel, M. S., and E. Y. Isacoff. 1997. A Genetically Encoded Optical Probe of Membrane Voltage. Neuron 19:735–741. [10] [PubMed: 9354320]
  • Silverman, J. L., M. Yang, C. Lord, and J. N. Crawley. 2010. Behavioural Phenotyping Assays for Mouse Models of Autism. Nat. Rev. Neurosci. 11(7):490–502. [2] [PMC free article: PMC3087436] [PubMed: 20559336]
  • Sliwkowski, M. X., and I. Mellman. 2013. Antibody Therapeutics in Cancer. Science 341(6151):1192–1198. [13] [PubMed: 24031011]
  • Smith, S. M., C. F. Beckmann, J. Andersson, et al. 2013. Resting-State fMRI in the Human Connectome Project. NeuroImage 80:144–168. [14] [PMC free article: PMC3720828] [PubMed: 23702415]
  • Solanto, M. V., H. Abikoff, E. Sonuga-Barke, et al. 2001. The Ecological Validity of Delay Aversion and Response Inhibition as Measures of Impulsivity in AD/HD: A Supplement to the NIMH Multimodal Treatment Study of AD/HD. J. Abnorm. Child Psychol. 29(3):215–228. [12] [PubMed: 11411784]
  • Sowman, P. F., S. S. Dueholm, J. H. Rasmussen, and N. Mrachacz-Kersting. 2014. Induction of Plasticity in the Human Motor Cortex by Pairing an Auditory Stimulus with TMS. Front. Hum. Neurosci. 8:398. [10] [PMC free article: PMC4042887] [PubMed: 24917810]
  • Spencer, B., R. A. Marr, R. Gindi, et al. 2011. Peripheral Delivery of a CNS Targeted, Metalo-Protease Reduces Abeta Toxicity in a Mouse Model of Alzheimer’s Disease. PLoS One 6(1):e16575. [7] [PMC free article: PMC3031588] [PubMed: 21304989]
  • Sperling, R. A., P. S. Aisen, L. A. Beckett, et al. 2011a. Toward Defining the Preclinical Stages of Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease. Alzheimers Dement. 7(3):280–292. [7] [PMC free article: PMC3220946] [PubMed: 21514248]
  • Sperling, R. A., C. R. Jack, Jr., and P. S. Aisen. 2011b. Testing the Right Target and Right Drug at the Right Stage. Sci. Transl. Med. 3(111):111cm133. [6] [PMC free article: PMC3752906] [PubMed: 22133718]
  • Spiegel, R., M. Berres, A. R. Miserez, and A. U. Monsch. 2011. For Debate: Substituting Placebo Controls in Long-Term Alzheimer’s Prevention Trials. Alzheimers Res. Ther. 3(2):9. [6] [PMC free article: PMC3226271] [PubMed: 21418632]
  • Spooren, W., L. Lindemann, A. Ghosh, and L. Santarelli. 2012. Synapse Dysfunction in Autism: A Molecular Medicine Approach to Drug Discovery in Neurodevelopmental Disorders. Trends Pharmacol. Sci. 33(12):669–684. [2] [PubMed: 23084458]
  • Squire, L. R. 1992. Memory and the Hippocampus: A Synthesis from Findings with Rats, Monkeys, and Humans. Psychol. Rev. 99:195–231. [12] [PubMed: 1594723]
  • Stein, T. D., V. E. Alvarez, and A. C. McKee. 2014. Chronic Traumatic Encephalopathy: A Spectrum of Neuropathological Changes Following Repetitive Brain Trauma in Athletes and Military Personnel. Alzheimers Res. Ther. 6(1):4. [7] [PMC free article: PMC3979082] [PubMed: 24423082]
  • Steinberg, E. E., J. R. Boivin, B. T. Saunders, et al. 2014. Positive Reinforcement Mediated by Midbrain Dopamine Neurons Requires D1 and D2 Receptor Activation in the Nucleus Accumbens. PLoS One 14(9):e94771. [14] [PMC free article: PMC3986242] [PubMed: 24733061]
  • Steinberg, J., and C. Webber. 2013. The Roles of FMRP-Regulated Genes in Autism Spectrum Disorder: Single- and Multiple-Hit Genetic Etiologies. Am. J. Hum. Genet. 93(5):825–839. [4] [PMC free article: PMC3824119] [PubMed: 24207117]
  • Stella, S. L., A. Vila, A. Y. Hung, et al. 2012. Association of Shank 1a Scaffolding Protein with Cone Photoreceptor Terminals in the Mammalian Retina. PLoS One 7:e43463. [10] [PMC free article: PMC3440378] [PubMed: 22984429]
  • Stephan, A. H., D. V. Madison, J. M. Mateos, et al. 2013. A Dramatic Increase of C1q Protein in the CNS During Normal Aging. J. Neurosci. 33(33):13460–13474. [5] [PMC free article: PMC3742932] [PubMed: 23946404]
  • Stewart, A. M., O. Braubach, J. Spitsbergen, R. Gerlai, and A. V. Kalueff. 2014. Zebrafish Models for Translational Neuroscience Research: From Tank to Bedside. Trends Neurosci. 37:264–278. [8] [PMC free article: PMC4039217] [PubMed: 24726051]
  • St. Johnston, D. 2002. The Art and Design of Genetic Screens: Drosophila Melanogaster. Nat. Rev. Genet. 3:176–188. [8] [PubMed: 11972155]
  • Stoner, R., M. L. Chow, M. P. Boyle, et al. 2014. Patches of Disorganization in the Neocortex of Children with Autism. N. Engl. J. Med. 370(13):1209–1219. [2] [PMC free article: PMC4499461] [PubMed: 24670167]
  • St-Pierre, F., J. D. Marshall, Y. Yang, et al. 2014. High-Fidelity Optical Reporting of Neuronal Electrical Activity with an Ultrafast Fluorescent Voltage Sensor. Nature Neurosci. 17(6):884–889. [10] [PMC free article: PMC4494739] [PubMed: 24755780]
  • Strittmatter, W. J., and A. D. Roses. 1996. Apolipoprotein E and Alzheimer’s Disease. Annu. Rev. Neurosci. 19:53–77. [7] [PubMed: 8833436]
  • Stuart, S. A., P. Butler, M. Munafo, D. J. Nutt, and E. S. J. Robinson. 2013. A Translational Rodent Assay of Affective Biases in Depression and Antidepressant Therapy. Neuropsychopharmacology 38:1625–1635. [12] [PMC free article: PMC3717539] [PubMed: 23503126]
  • Sullivan, P. F., M. J. Daly, and M. C. O’Donovan. 2012. Genetic Architectures of Psychiatric Disorders: The Emerging Picture and Its Implications. Nat. Rev. Genet. 13(8):537–551. [3] [PMC free article: PMC4110909] [PubMed: 22777127]
  • Sullivan, P. F., K. S. Kendler, and M. C. Neale. 2003. Schizophrenia as a Complex Trait: Evidence from a Meta-Analysis of Twin Studies. Arch. Gen. Psychiatry 60(12):1187–1192. [13] [PubMed: 14662550]
  • Swainson, R., J. R. Hodges, C. J. Galton, et al. 2001. Early Detection and Differential Diagnosis of Alzheimer’s Disease and Depression with Neuropsychological Tasks. Dement. Geri. Cogn. Dis. 12:265–280. [12] [PubMed: 11351138]
  • Szatmari, P., A. D. Paterson, L. Zwaigenbaum, et al. 2007. Mapping Autism Risk Loci Using Genetic Linkage and Chromosomal Rearrangements. Nat. Genet. 39(3):319–328. [2] [PMC free article: PMC4867008] [PubMed: 17322880]
  • Tabbal, S. D., L. Tian, M. Karimi, et al. 2012. Low Nigrostriatal Reserve for Motor Parkinsonism in Nonhuman Primates. Exp. Neurol. 237:355–362. [9] [PMC free article: PMC3443325] [PubMed: 22836146]
  • Tabuchi, K., J. Blundell, M. R. Etherton, et al. 2007. A Neuroligin-3 Mutation Implicated in Autism Increases Inhibitory Synaptic Transmission in Mice. Science 318(5847):71–76. [2] [PMC free article: PMC3235367] [PubMed: 17823315]
  • Takahashi, D. Y., D. Z. Narayanan, and A. A. Ghazanfar. 2013. Coupled Oscillator Dynamics of Vocal Turn-Taking in Monkeys. Curr. Biol. 23:2162–2168. [8] [PubMed: 24139740]
  • Takahashi, K., K. Tanabe, M. Ohnuki, et al. 2007. Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors. Cell 131:861–872. [8, 11] [PubMed: 18035408]
  • Takahashi, K., and S. Yamanaka. 2006. Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors. Cell 126:663–676. [8, 11] [PubMed: 16904174]
  • Talpos, J. C., B. D. Winters, R. Dias, L. M. Saksida, and T. J. Bussey. 2009. A Novel Touchscreen Automated Paired-Associate Learning (PAL) Task Sensitive to Pharmacological Manipulation of the Hippocampus: A Translational Rodent Model of Cognitive Impairments in Neurodegenerative Disease. Psychopharmacology 205:157–168. [12] [PubMed: 19357840]
  • Taylor Tavares, J. V., L. Clark, M. L. Furey, et al. 2008. Neural Basis of Abnormal Response to Negative Feedback in Unmedicated Mood Disorders. NeuroImage 42(3):1118–1126. [12] [PMC free article: PMC2745889] [PubMed: 18586109]
  • Testa-Silva, G., M. B. Verhoog, N. A. Goriounova, et al. 2010. Human Synapses Show a Wide Temporal Window for Spike-Timing-Dependent Plasticity. Front. Synaptic Neurosci. 2:12. [10] [PMC free article: PMC3059666] [PubMed: 21423498]
  • Teyler, T. J., J. P. Hamm, W. C. Clapp, et al. 2005. Long-Term Potentiation of Human Visual Evoked Responses. Eur. J. Neurosci. 21:2045–2050. [10] [PMC free article: PMC1226326] [PubMed: 15869500]
  • Thut, G., and A. Pascual-Leone. 2010. A Review of Combined TMS-EEG Studies to Characterize Lasting Effect of Repetitive TMS and Assess Their Usefuleness in Cognitive and Clinical Neuroscience. Brain Topogr. 22:219–232. [10] [PMC free article: PMC3260526] [PubMed: 19862614]
  • Tian, G., and D. Finley. 2012. Cell Biology: Destruction Deconstructed. Nat. Chem. Biol. 482(7384):170–171. [5] [PubMed: 22318600]
  • Toro, R., M. Konyukh, R. Delorme, et al. 2010. Key Role for Gene Dosage and Synaptic Homeostasis in Autism Spectrum Disorders. Trends Genet. 26(8):363–372. [2] [PubMed: 20609491]
  • Toro, R., J. B. Poline, G. Huguet, et al. 2014. Genomic Architecture of Human Neuroanatomical Diversity. Mol. Psychiatry: doi: 10.1038/mp.2014.1099. [2] [CrossRef]
  • Toyomaki, A., I. Kusumi, T. Matsuyama, et al. 2008. Tone Duration Mismatch Negativity Deficits Predict Impairment of Executive Function in Schizophrenia. Prog. Neuropsychopharmacol. Biol. Psychiatry 32:95–99. [10] [PubMed: 17764800]
  • Tremblay, M. E., and A. K. Majewska. 2011. A Role for Microglia in Synaptic Plasticity? Commun. Integr. Biol. 4(2):220–222. [7] [PMC free article: PMC3104585] [PubMed: 21655446]
  • Tritsch, N. X., J. B. Ding, and B. L. Sabatini. 2012. Dopaminergic Neurons Inhibit Striatal Output through Non-Canonical Release of GABA. Nature 490:262–266. [10] [PMC free article: PMC3944587] [PubMed: 23034651]
  • Tropea, D., E. Giacometti, N. R. Wilson, et al. 2009. Partial Reversal of Rett Syndrome-Like Symptoms in MeCP2 Mutant Mice. PNAS 106:2029–2034. [10] [PMC free article: PMC2644158] [PubMed: 19208815]
  • Tulving, E. 1983. Elements of Episodic Memory. Oxford Oxford Univ. Press. [12]
  • Turetsky, B. I., M. E. Calkins, G. A. Light, et al. 2007a. Neurophysiological Endophenotypes of Schizophrenia: The Viability of Selected Candidate Measures. Schizophr. Bull. 33:69–94. [10] [PMC free article: PMC2632291] [PubMed: 17135482]
  • Turetsky, B. I., C. G. Kohler, T. Indersmitten, et al. 2007b. Facial Emotion Recognition in Schizophrenia: When and Why Does It Go Awry? Schizophr. Res. 94:253–263. [10] [PMC free article: PMC2571079] [PubMed: 17583481]
  • Turner, D. C., L. Clark, and E. Pomarol-Clotet. 2004. Modafinil Improves Cognition and Attentional Set Shifting in Patients with Chronic Schizophrenia. Neuropsychopharmacology 29:1363–1373. [12] [PubMed: 15085092]
  • Tye, K. M., and K. Deisseroth. 2012. Optogenetic Investigation of Neural Circuits Underlying Brain Disease in Animal Models. Nat. Rev. Neurosci. 13(4):251–266. [8] [PMC free article: PMC6682316] [PubMed: 22430017]
  • Tye, K. M., J. J. Mirzabekov, M. R. Warden, et al. 2013. Dopamine Neurons Modulate Neural Encoding and Expression of Depression-Related Behaviour. Nature 493:537–541. [9] [PMC free article: PMC4160519] [PubMed: 23235822]
  • Tye, K. M., R. Prakash, S.-Y. Kim, et al. 2011. Amygdala Circuitry Mediating Reversible and Bidirectional Control of Anxiety. Nature 471(7338):358–362. [8] [PMC free article: PMC3154022] [PubMed: 21389985]
  • Ugurbil, K., J. Xu, E. J. Auerbach, et al. 2013. Pushing Spatial and Temporal Resolution for Functional and Diffusion MRI in the Human Connectome Project. Neuroimage 80:80–104. [9] [PMC free article: PMC3740184] [PubMed: 23702417]
  • Uhlhaas, P. J., and W. Singer. 2006. Neural Synchrony in Brain Disorders: Relevance for Cognitive Dysfunctions and Pathophysiology. Neuron 52:155–168. [10] [PubMed: 17015233]
  • Umbricht, D., and S. Krljes. 2005. Mismatch Negativity in Schizophrenia: A Meta-Analysis. Schizophr. Res. 76:1–23. [10] [PubMed: 15927795]
  • van de Leemput, I. A., M. Wichers, A. O. Cramer, et al. 2014. Critical Slowing Down as Early Warning for the Onset and Termination of Depression. PNAS 111(1):87–92. [4] [PMC free article: PMC3890822] [PubMed: 24324144]
  • van den Broeke, E. N., C. M. van Rijn, J. A. Biurrun Manresa, et al. 2010. Neurophysiological Correlates of Nociceptive Heterosynaptic Long-Term Potentiation in Humans. J. Neurophysiol. 103:2107–2113. [10] [PubMed: 20164395]
  • Van Essen, D. C., S. M. Smith, D. M. Barch, et al. 2013. The WU-Minn Human Connectome Project: An Overview. Neuroimage 80:62–79. [7] [PMC free article: PMC3724347] [PubMed: 23684880]
  • van Os, J., P. Delespaul, J. Wigman, I. Myin-Germeys, and M. Wichers. 2013. Beyond DSM and ICD: Introducing “Precision Diagnosis” for Psychiatry Using Momentary Assessment Technology. World Psychiatry 12(2):113–117. [4] [PMC free article: PMC3683255] [PubMed: 23737412]
  • Varga, V., A. Losonczy, B. V. Zemelman, et al. 2009. Fast Synaptic Subcortical Control of Hippocampal Circuits. Science 326:449–453. [10] [PubMed: 19833972]
  • Varoqueaux, F., G. Aramuni, R. L. Rawson, et al. 2006. Neuroligins Determine Synapse Maturation and Function. Neuron 51(6):741–754. [2] [PubMed: 16982420]
  • Varrone, A., and C. Halldin. 2012. New Developments of Dopaminergic Imaging in Parkinson’s Disease. Q. J. Nucl. Med. Mol. Imaging [7] [PubMed: 22402820]
  • Vellucci, S. V., P. J. Martin, and B. J. Everitt. 1988. The Discriminative Stimulus Produced by Penntylenetrazole: Effects of Systemic Anxiolytics and Anxiogenics. Aggressive Defeat and Midazolam or Muscimol Infused into the Amygdala. J. Psychopharmacol. 2:809–893. [12] [PubMed: 22155842]
  • Verkerk, A. J., M. Pieretti, J. S. Sutcliffe, et al. 1991. Identification of a Gene (FMR-1) Containing a CGG Repeat Coincident with a Breakpoint Cluster Region Exhibiting Length Variation in Fragile X Syndrome. Cell 65(5):905–914. [13] [PubMed: 1710175]
  • Verret, L., E. O. Mann, G. B. Hang, et al. 2012. Inhibitory Interneuron Deficit Links Altered Network Activity and Cognitive Dysfunction in Alzheimer Model. Cell 149(3):708–721. [13] [PMC free article: PMC3375906] [PubMed: 22541439]
  • Vierbuchen, T., A. Ostermeier, Z. P. Pang, et al. 2010. Direct Conversion of Fibroblasts to Functional Neurons by Defined Factors. Nature 463(7284):1035–1041. [13] [PMC free article: PMC2829121] [PubMed: 20107439]
  • Vierbuchen, T., and M. Wernig. 2011. Direct Lineage Conversions: Unnatural but Useful? Nat. Biotechnol. 29(10):892–907. [13] [PMC free article: PMC3222779] [PubMed: 21997635]
  • Vincent, J. L., G. H. Patel, M. D. Fox, et al. 2007. Intrinsic Functional Architecture in the Anaesthetized Monkey Brain. Nature 447:83–86. [9] [PubMed: 17476267]
  • Voineagu, I., X. Wang, P. Johnston, et al. 2011. Transcriptomic Analysis of Autistic Brain Reveals Convergent Molecular Pathology. Nature 474(7351):380–384. [2] [PMC free article: PMC3607626] [PubMed: 21614001]
  • Voisine, C., J. S. Pedersen, and R. I. Morimoto. 2010. Chaperone Networks: Tipping the Balance in Protein Folding Diseases. Neurobiol. Dis. 40(1):12–20. [5] [PMC free article: PMC3429345] [PubMed: 20472062]
  • Volk, D. W., and D. A. Lewis. 2010. Prefrontal Cortical Circuits in Schizophrenia. Curr. Top. Behav. Neurosci. 4:485–508. [8] [PubMed: 21312410]
  • Voon, V., M. A. Irvine, K. Derbyshire, et al. 2014. Measuring “Waiting” Impulsivity in Substance Addictions and Binge Eating Disorder in a Novel Analogue of Rodent Serial Reaction Time Task. Biol. Psychiatry 75:148–155. [12] [PMC free article: PMC3988873] [PubMed: 23790224]
  • Voronin, L. L. 1994. Quantal Analysis of Hippocampal Long-Term Potentiation. Rev. Neurosci. 5:141–170. [10] [PubMed: 7827708]
  • Vos, T., A. D. Flaxman, M. Naghavi, et al. 2012. Years Lived with Disability (YLDs) for 1160 Sequelae of 289 Diseases and Injuries 1990–2010: A Systematic Analysis for the Global Burden of Disease Study 2010. Lancet 380:2163–2196. [1] [PMC free article: PMC6350784] [PubMed: 23245607]
  • Vossel, K. A., A. J. Beagle, G. D. Rabinovici, et al. 2013. Seizures and Epileptiform Activity in the Early Stages of Alzheimer Disease. JAMA Neurol. 70(9):1158–1166. [6, 13] [PMC free article: PMC4013391] [PubMed: 23835471]
  • Walker, L. C., M. I. Diamond, K. E. Duff, and B. T. Hyman. 2013. Mechanisms of Protein Seeding in Neurodegenerative Diseases. JAMA Neurol. 70:304–310. [9] [PMC free article: PMC3665718] [PubMed: 23599928]
  • Wang, D., S. S. El-Amouri, M. Dai, et al. 2013a. Engineering a Lysosomal Enzyme with a Derivative of Receptor-Binding Domain of apoE Enables Delivery across the Blood-Brain Barrier. PNAS 110(8):2999–3004. [7] [PMC free article: PMC3581871] [PubMed: 23382178]
  • Wang, H., H. Yang, C. S. Shivalila, et al. 2013b. One-Step Generation of Mice Carrying Mutations in Multiple Genes by CRISPR/Cas-Mediated Genome Engineering. Cell 153:910–918. [9] [PMC free article: PMC3969854] [PubMed: 23643243]
  • Wang, J., F. Wagner, D. A. Borton, et al. 2012. Integrated Device for Combined Optical Neuromodulation and Electrical Recording for Chronic in Vivo Applications. J. Neural Eng. 9(1):016001. [13] [PubMed: 22156042]
  • Wang, J., X. Zuo, and Y. He. 2010a. Graph-Based Network Analysis of Resting-State Functional MRI. Front. Syst. Neurosci. 4:15. [9] [PMC free article: PMC2893007] [PubMed: 20589099]
  • Wang, P., Y. Xue, X. Shang, and Y. Liu. 2010b. Diphtheria Toxin Mutant CRM197-Mediated Transcytosis across Blood-Brain Barrier in vitro. Cell. Mol. Neurobiol. 30(5):717–725. [7] [PubMed: 20082134]
  • Wang, W. Y., B. J. Barratt, D. G. Clayton, and J. A. Todd. 2005. Genome-Wide Association Studies: Theoretical and Practical Concerns. Nat. Rev. Genet. 6:109–118. [3] [PubMed: 15716907]
  • Wang, X., P. A. McCoy, R. M. Rodriguiz, et al. 2011. Synaptic Dysfunction and Abnormal Behaviors in Mice Lacking Major Isoforms of Shank3. Hum. Mol. Genet. 20(15):3093–3108. [4] [PMC free article: PMC3131048] [PubMed: 21558424]
  • Wang, Y., H.-F. Guo, T. A. Pologruto, et al. 2004. Stereotyped Odor-Evoked Activity in the Mushroom Body of Drosophila Revealed by Green Fluorescent Protein-Based Ca2+ Imaging. J. Neurosci. 24:6507–6514. [10] [PMC free article: PMC6729867] [PubMed: 15269261]
  • Ward, N. M., and V. J. Brown. 1996. Covert Orienting of Attention in the Rat and the Role of Striatal Dopamine. J. Neurosci. 16:3082–3088. [12] [PMC free article: PMC6579048] [PubMed: 8622137]
  • Watson, K. K., and M. L. Platt. 2012. Of Mice and Monkeys: Using Non-Human Primate Models to Bridge Mouse- and Human-Based Investigations of Autism Spectrum Disorders. J. Neurodev. Disord. 4(1):21. [13] [PMC free article: PMC3445833] [PubMed: 22958282]
  • Watts, J. C., K. Giles, A. Oehler, et al. 2013. Transmission of Multiple System Atrophy Prions to Transgenic Mice. PNAS 110(48):19555–19560. [5] [PMC free article: PMC3845125] [PubMed: 24218576]
  • Wei, F., and M. Zhuo. 2001. Potentiation of Sensory Responses in the Anterior Cingulate Cortex Following Digit Amputation in the Anaesthetised Rat. J. Physiol. 532:823–833. [10] [PMC free article: PMC2278568] [PubMed: 11313449]
  • Weinberger, D. R. 1987. Implications of Normal Brain Development for the Pathogenesis of Schizophrenia. Arch. Gen. Psychiatry 44(7):660–669. [3, 13] [PubMed: 3606332]
  • Weiner, I. 2003. The “Two-Headed” Latent Inhibition Model of Schizophrenia: Modeling Positive and Negative Symptoms and Their Treatment. Psychopharmacology 169:257–297. [12] [PubMed: 12601500]
  • Weiss, I. C., A. M. Domeney, C. A. Heidbreder, J. L. Moreau, and J. Feldon. 2001. Early Social Isolation, but Not Maternal Separation, Affects Behavioral Sensitization to Amphetamine in Male and Female Adult Rats. Pharmacol. Biochem. Behav. 70(2–3):397–409. [13] [PubMed: 11701213]
  • Welch, J. M., J. Lu, R. M. Rodriguiz, et al. 2007. Cortico-Striatal Synaptic Defects and OCD-Like Behaviors in SAPAP3 Mutant Mice. Nature 448:894–900. [8] [PMC free article: PMC2442572] [PubMed: 17713528]
  • Wichmann, T., H. Bergman, and M. R. DeLong. 1994. The Primate Subthalamic Nucleus. III. Changes in Motor Behavior and Neuronal Activity in the Internal Pallidum Induced by Subthalamic Inactivation in the MPTP Model of Parkinsonism. J. Neurophysiol. 72:521–531. [9] [PubMed: 7983516]
  • Wichmann, T., H. Bergman, P. A. Starr, et al. 1999. Comparison of MPTP-Induced Changes in Spontaneous Neuronal Discharge in the Internal Pallidal Segment and in the Substantia Nigra Pars Reticulata in Primates. Exp. Brain Res. 125:397–409. [9] [PubMed: 10323285]
  • Wichterle, H., I. Lieberam, J. A. Porter, and T. M. Jessell. 2002. Directed Differentiation of Embryonic Stem Cells into Motor Neurons. Cell 110:385–397. [11] [PubMed: 12176325]
  • Wickersham, I. R., S. Finke, K. Conzelmann, and E. M. Callaway. 2007. Retrograde Neuronal Tracing with a Deletion-Mutant Rabies Virus. Nat. Methods 4:47–49. [10] [PMC free article: PMC2755236] [PubMed: 17179932]
  • Wicks, P., T. E. Vaughan, M. P. Massagli, and J. Heywood. 2011. Accelerated Clinical Discovery Using Self-Reported Patient Data Collected Online and a Patient-Matching Algorithm. Nat. Biotechnol. 29(5):411–414. [2] [PubMed: 21516084]
  • Wietek, J., J. S. Wiegert, N. Adeishvili, et al. 2014. Conversion of Channelrhodopsin into a Light-Gated Chloride Channel. Science 344(6182):409–412. [10] [PubMed: 24674867]
  • Williams, H. J., N. Craddock, G. Russo, et al. 2011. Most Genome-Wide Significant Susceptibility Loci for Schizophrenia and Bipolar Disorder Reported to Date Cross-Traditional Diagnostic Boundaries. Hum. Mol. Genet. 20(2):387–391. [3] [PubMed: 21037240]
  • Willsey, A. J., S. J. Sanders, M. Li, et al. 2013. Coexpression Networks Implicate Human Midfetal Deep Cortical Projection Neurons in the Pathogenesis of Autism. Cell 155(5):997–1007. [2, 10] [PMC free article: PMC3995413] [PubMed: 24267886]
  • Wing, J., and J. Nixon. 1975. Discriminating Symptoms in Schizophrenia: A Report from the International Pilot Study of Schizophrenia. Arch. Gen. Psychiatry 32(7):853–859. [4] [PubMed: 1156104]
  • Winstanley, C. A., D. E. H. Theobald, R. N. Cardinal, and T. W. Robbins. 2004. Contrasting Roles of Basolateral Amygdala and Orbitofrontal Cortex in Impulsive Choice. J. Neurosci. 24:4718–4722. [12] [PMC free article: PMC6729470] [PubMed: 15152031]
  • Wise, R. 2004. Dopamine, Learning and Motivation. Nat. Rev. Neurosci. 5:483–494. [12] [PubMed: 15152198]
  • Wohr, M., F. I. Roullet, A. Y. Hung, M. Sheng, and J. N. Crawley. 2011. Communication Impairments in Mice Lacking Shank1: Reduced Levels of Ultrasonic Vocalizations and Scent Marking Behavior. PLoS One 6(6):e20631. [4] [PMC free article: PMC3111434] [PubMed: 21695253]
  • Wolf, A. B., J. Valla, G. Bu, et al. 2013. Apolipoprotein E as a Beta-Amyloid-Independent Factor in Alzheimer’s Disease. Alzheimers Res. Ther. 5(5):38. [7] [PMC free article: PMC3979087] [PubMed: 23998393]
  • Wolters, A., F. Sandbrink, A. Schlottmann, et al. 2003. A Temporally Asymmetric Hebbian Rule Governing Plasticity in the Human Motor Cortex. J. Neurophysiol. 89:2339–2345. [10] [PubMed: 12612033]
  • Wolters, A., A. Schmidt, A. Schramm, et al. 2005. Timing-Dependent Plasticity in Human Primary Somatosensory Cortex. J. Physiol. 565:1039–1052. [10] [PMC free article: PMC1464551] [PubMed: 15845584]
  • Won, H., H. R. Lee, H. Y. Gee, et al. 2012. Autistic-Like Social Behaviour in Shank2-Mutant Mice Improved by Restoring NMDA Receptor Function. Nature 486(7402):261–265. [2, 4] [PubMed: 22699620]
  • Wood, S. J., C. Pantelis, T. Proffitt, et al. 2003. Spatial Working Memory Ability Is a Marker of Risk-for-Psychosis. Psychol. Med. 33:1239–1247. [12] [PubMed: 14580078]
  • Wooding, S., A. Pollitt, S. Castle-Clarke, et al. 2013. Mental Health Retrosight. Understanding the Returns from Research (Lessons from Schizophrenia). RAND Corporation. [4] [PMC free article: PMC5051976] [PubMed: 28083322]
  • Wooten, G. F., and R. C. Collins. 1981. Metabolic Effects of Unilateral Lesion of the Substantia Nigra. J. Neurosci. 1:285–291. [9] [PMC free article: PMC6564122] [PubMed: 7264720]
  • Worbe, Y., G. Savulich, V. Voon, E. Fernandez-Egea, and T. W. Robbins. 2014. Serotonin Depletion Induces “Waiting Impulsivity” on the Human Four Choice Serial Reaction Time Task: Cross-Species Translational Significance. Neuropsychopharmacology 39:1519–1526. [12] [PMC free article: PMC3988556] [PubMed: 24385133]
  • Wynn, J. K., C. Sugar, W. P. Horan, R. Kern, and M. F. Green. 2010. Mismatch Negativity, Social Cognition, and Functioning in Schizophrenia Patients. Biol. Psychiatry 67:940–947. [10] [PMC free article: PMC2862843] [PubMed: 20074704]
  • Xia, C. F., J. Arteaga, G. Chen, et al. 2013. [(18)F]T807, a Novel Tau Positron Emission Tomography Imaging Agent for Alzheimer’s Disease. Alzheimers Dement. 9(6):666–676. [7] [PubMed: 23411393]
  • Xu, W., W. Morishita, P. S. Buckmaster, et al. 2012. Distinct Neuronal Coding Schemes in Memory Revealed by Selective Erasure of Fast Synchronous Synaptic Transmission. Neuron 73:990–1001. [10] [PMC free article: PMC3319466] [PubMed: 22405208]
  • Yamanaka, S. 2007. Strategies and New Developments in the Generation of Patient-Specific Pluripotent Stem Cells. Cell Stem Cell 1:39–49. [11] [PubMed: 18371333]
  • Yanamandra, K., N. Kfoury, H. Jiang, et al. 2013. Anti-Tau Antibodies That Block Tau Aggregate Seeding in Vitro Markedly Decrease Pathology and Improve Cognition in Vivo. Neuron 80(2):402–414. [7] [PMC free article: PMC3924573] [PubMed: 24075978]
  • Yang, J., B. Benyamin, B. P. McEvoy, et al. 2010. Common SNPs Explain a Large Proportion of the Heritability for Human Height. Nat. Genet. 42(7):565–569. [2] [PMC free article: PMC3232052] [PubMed: 20562875]
  • Yang, L., D. Rieves, and C. Ganley. 2012a. Brain Amyloid Imaging: FDA Approval of Florbetapir F18 Injection. N. Engl. J. Med. 367(10):885–887. [13] [PubMed: 22931256]
  • Yang, M., O. Bozdagi, M. L. Scattoni, et al. 2012b. Reduced Excitatory Neurotransmission and Mild Autism-Relevant Phenotypes in Adolescent Shank3 Null Mutant Mice. J. Neurosci. 32(19):6525–6541. [4] [PMC free article: PMC3362928] [PubMed: 22573675]
  • Yang, Y. M., S. K. Gupta, K. J. Kim, et al. 2013. A Small Molecule Screen in Stem-Cell-Derived Motor Neurons Identifies a Kinase Inhibitor as a Candidate Therapeutic for ALS. Cell Stem Cell 12:713–726. [11, 14] [PMC free article: PMC3707511] [PubMed: 23602540]
  • Yizhar, O., L. E. Fenno, M. Prigge, et al. 2011. Neocortical Excitation/Inhibition Balance in Information Processing and Social Dysfunction. Nature 477(7363):171–178. [8] [PMC free article: PMC4155501] [PubMed: 21796121]
  • Yu, D. X., M. C. Marchetto, and F. H. Gage. 2013a. Therapeutic Translation of iPSCs for Treating Neurological Disease. Cell Stem Cell 12:678–688. [11] [PubMed: 23746977]
  • Yu, T. W., M. H. Chahrour, M. E. Coulter, et al. 2013b. Using Whole-Exome Sequencing to Identify Inherited Causes of Autism. Neuron 77(2):259–273. [2] [PMC free article: PMC3694430] [PubMed: 23352163]
  • Yue, Z., Q. J. Wang, and M. Komatsu. 2008. Neuronal Autophagy: Going the Distance to the Axon. Autophagy 4(1):94–96. [5] [PMC free article: PMC2675167] [PubMed: 18000396]
  • Zaehle, T., W. C. Clapp, J. P. Hamm, M. Meyer, and I. J. Kirk. 2007. Induction of LTP-Like Changes in Human Auditory Cortex by Rapid Auditory Stimulation: An fMRI Study. Restor. Neurol. Neurosci. 25:251–259. [10] [PubMed: 17943003]
  • Zahs, K. R., and K. H. Ashe. 2010. Too Much Good News: Are Alzheimer Mouse Models Trying to Tell Us How to Prevent, Not Cure, Alzheimer’s Disease? Trends Neurosci. 33(8):381–389. [6] [PubMed: 20542579]
  • Zeeb, F. D., T. W. Robbins, and C. A. Winstanley. 2009. Serotonergic and Dopaminergic Modulation of Gambling Behavior as Assessed Using a Novel Rat Gambling Task. Neuropsychopharmacology 34:2329–2343. [12] [PubMed: 19536111]
  • Zhang, F., L. Cong, S. Lodato, et al. 2011. Efficient Construction of Sequence-Specific TAL Effectors for Modulating Mammalian Transcription. Nat. Biotechnol. 29:149–153. [8] [PMC free article: PMC3084533] [PubMed: 21248753]
  • Zhang, Y., C. Pak, Y. Han, et al. 2013. Rapid Single-Step Induction of Functional Neurons from Human Pluripotent Stem Cells. Neuron 78:785–798. [1, 8, 11] [PMC free article: PMC3751803] [PubMed: 23764284]
  • Zhao, S., J. T. Ting, H. E. Atallah, et al. 2011. Cell Type–Specific Channelrhodopsin-2 Transgenic Mice for Optogenetic Dissection of Neural Circuitry Function. Nat. Methods 8(9):745–752. [8] [PMC free article: PMC3191888] [PubMed: 21985008]
  • Zhou, Z., H. Zhu, and L. Chen. 2013. Effect of Aripiprazole on Mismatch Negativity (MMN) in Schizophrenia. PLoS One 8:e52186. [10] [PMC free article: PMC3538635] [PubMed: 23308105]
  • Zhu, X., A. C. Need, S. Petrovski, and D. B. Goldstein. 2014. One Gene, Many Neuropsychiatric Disorders: Lessons from Mendelian Diseases. Nat. Neurosci. 17(6):773–781. [2] [PubMed: 24866043]
  • Ziemann, U., T. V. Ilić, T. V. Iliać, et al. 2004. Learning Modifies Subsequent Induction of Long-Term Potentiation-Like and Long-Term Depression-Like Plasticity in Human Motor Cortex. J. Neurosci. 24:1666–1672. [10] [PMC free article: PMC6730462] [PubMed: 14973238]
  • Ziemann, U., W. Paulus, M. A. Nitsche, et al. 2008. Consensus: Motor Cortex Plasticity Protocols. Brain Stimul. 1:164–182. [10] [PubMed: 20633383]
  • Zimmermann, P., M. Gondan, and B. Fimm. 2004. KiTAP Testbatterie zur Aufmerksamkeitsprüfung für Kinder. Freiburg: Psytest. [10]
  • Zlokovic, B. V. 2008. The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders. Neuron 57(2):178–201. [7] [PubMed: 18215617]
© 2015 Massachusetts Institute of Technology and the Frankfurt Institute for Advanced Studies.

All rights reserved. No part of this book may be reproduced in any form by electronic or mechanical means (including photocopying, recording, or information storage and retrieval) without permission in writing from the publisher.

MIT Press books may be purchased at special quantity discounts for business or sales promotional use. For information, please email ude.tim.sserptim@selas_laiceps.

Licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported license. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/

Bookshelf ID: NBK569705

Views

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...